Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2526918724572737e-42,23.554133333333333,2258.757722782574,"['RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL36', 'RPL35', 'RPL38', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPS4Y1', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",1.135356703718466e-39,0,0,61
2,Nuclear Receptors Meta-Pathway WP2882,1.1915769522388899e-05,2.401949763079006,27.232460603596447,"['SRXN1', 'MGST1', 'IRS2', 'DBI', 'SLC6A1', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'AKAP13', 'DNAJB1', 'HES1', 'JUNB', 'CBR3', 'EGR1', 'SREBF1', 'NQO1', 'JUN', 'HSP90AA1', 'GADD45B', 'SLC6A16', 'HGF', 'SLC39A11', 'NRG1', 'SLC39A14', 'SOD3', 'NFKB2', 'SLC2A9', 'SLC5A9', 'SCD', 'SPINK13', 'SPRY1', 'ANGPTL4', 'GCLM', 'EPHA3', 'HSPA1A', 'FKBP5', 'FTL']",0.0022306671136817172,0,0,37
3,Hematopoietic Stem Cell Differentiation WP2849,1.7281651932364473e-05,7.704790249433106,84.4896912789561,"['HES6', 'CIITA', 'KITLG', 'NOTCH1', 'CSF1', 'TRIM29', 'PIM1', 'NFATC2', 'FOS', 'RUNX1']",0.0022306671136817172,0,0,10
4,Differentiation Pathway WP2848,1.7703707251442202e-05,9.240441801189466,101.1064792497933,"['NT5E', 'KITLG', 'WNT2B', 'NOTCH1', 'CSF1', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.0022306671136817172,0,0,9
5,Complement system WP2806,7.375551816250544e-05,5.353908174692049,50.941123198742815,"['C3', 'LAMA5', 'RPS19', 'C1S', 'C1R', 'PROS1', 'SERPING1', 'CD59', 'LAMB1', 'KLKB1', 'ICAM1']",0.005978879467292254,0,0,11
6,Spinal Cord Injury WP2431,8.49081815873715e-05,3.273771152296535,30.688134689111646,"['EGR1', 'BTG2', 'IL1R1', 'GADD45A', 'XYLT1', 'PLA2G5', 'FOS', 'ICAM1', 'GFAP', 'TNFSF13B', 'LGALS3', 'ZFP36', 'VCAN', 'GAP43', 'COL4A1', 'APEX1', 'CCNG1', 'SLIT3']",0.005978879467292254,0,0,18
7,Complement and Coagulation Cascades WP558,9.162797840095411e-05,8.20675344274665,76.30453789692957,"['C3', 'CPB2', 'C1S', 'C1R', 'PROS1', 'SERPING1', 'F3', 'KLKB1']",0.005978879467292254,0,0,8
8,"GPCRs, Class A Rhodopsin-like WP455",9.490284868717863e-05,4.297314578005115,39.804550248192,"['P2RY12', 'GPR39', 'OXTR', 'P2RY14', 'GPR87', 'OR2H2', 'GPR22', 'CHRM5', 'EDNRA', 'GPR161', 'GPR171', 'ACKR4', 'NTSR2']",0.005978879467292254,0,0,13
9,NRF2 pathway WP2884,0.00011714205130477519,2.9464455879550218,26.671588599479236,"['EGR1', 'NQO1', 'HSP90AA1', 'SRXN1', 'SLC6A16', 'HGF', 'SLC39A11', 'NRG1', 'SLC6A1', 'SLC5A3', 'SLC39A14', 'SOD3', 'SLC2A9', 'DNAJB1', 'SLC5A9', 'GCLM', 'EPHA3', 'FTL', 'CBR3', 'HSPA1A']",0.006559954873067411,0,0,20
10,Gene regulatory network modelling somitogenesis  WP2854,0.0001609886048095284,23.037679932260797,201.21517357719924,"['LFNG', 'RIPPLY2', 'NOTCH1', 'HES1', 'TBX6']",0.008113825682400232,0,0,5
11,Vitamin B12 metabolism WP1533,0.0003628222676468665,6.153367289190719,48.744498715638855,"['SERPINA3', 'CUBN', 'HBB', 'SOD2', 'LDLR', 'SOD3', 'ICAM1', 'NFKB2']",0.016623856626729154,0,0,8
12,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.0010208570894215839,3.361313303391668,23.149743610315966,"['SREBF1', 'CDKN1A', 'CEBPB', 'NOTCH1', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'HES5']",0.042875997755706524,0,0,12
13,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.0011822579224352967,18.41455160744501,124.12013944995269,"['LFNG', 'RIPPLY2', 'NOTCH1', 'TBX6']",0.04583523022364534,0,0,4
14,Overview of nanoparticle effects WP3287,0.001499690522544056,9.212531752751906,59.90445557481253,"['CCND3', 'COL4A1', 'LAMA3', 'FN1', 'PIK3CD']",0.05219165735285288,0,0,5
15,Genotoxicity pathway WP4286,0.0015533231355015738,3.387375886524823,21.907374857930904,"['ARRDC4', 'ACTA2', 'ITPKC', 'BTG2', 'CDKN1A', 'RPS27', 'DAAM1', 'CEBPD', 'GADD45A', 'PCDH8', 'TRIM22']",0.05219165735285288,0,0,11
16,Adipogenesis WP236,0.0025702179531663667,2.3838427042019856,14.216676676439121,"['SREBF1', 'CDKN1A', 'CEBPB', 'GADD45B', 'CEBPD', 'IRS1', 'GADD45A', 'IRS2', 'SFRP4', 'SOCS3', 'KLF6', 'SCD', 'NAMPT', 'PNPLA3', 'ID3', 'FAS', 'RXRG']",0.08069950029114517,0,0,17
17,Vitamin D Receptor Pathway WP2877,0.0027220069542648172,2.641638225255973,15.602534555009658,"['CDKN1A', 'SERPINB1', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'S100A6', 'CD9', 'PRKCQ', 'JUNB']",0.08069950029114517,0,0,14
18,Globo Sphingolipid Metabolism WP1424,0.00424243291779305,5.026502311248074,27.45786387701413,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'A4GALT', 'ST6GALNAC5']",0.10284804349009673,0,0,6
19,Alpha 6 Beta 4 signaling pathway WP244,0.004394293945485015,3.6893039049235994,20.023506613677093,"['LAMA5', 'LAMA2', 'SHC1', 'IRS1', 'LAMA3', 'GAB1', 'IRS2', 'LAMB1']",0.10284804349009673,0,0,8
20,Folate Metabolism WP176,0.004394293945485015,3.6893039049235994,20.023506613677093,"['SERPINA3', 'CSF1', 'HBB', 'SOD2', 'LDLR', 'SOD3', 'ICAM1', 'NFKB2']",0.10284804349009673,0,0,8
21,Development and heterogeneity of the ILC family WP3893,0.00469346230212743,9.205583756345177,49.35651737379498,"['NFIL3', 'IL7', 'ZBTB16', 'IL18']",0.10284804349009673,0,0,4
22,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.00469346230212743,9.205583756345177,49.35651737379498,"['CDKN1A', 'FAM20C', 'FGFR3', 'NFKB2']",0.10284804349009673,0,0,4
23,Inflammatory Response Pathway WP453,0.00469346230212743,9.205583756345177,49.35651737379498,"['LAMA5', 'FN1', 'LAMB1', 'TNFRSF1A']",0.10284804349009673,0,0,4
24,Breast cancer pathway WP4262,0.00509505801082872,2.0934732933447586,11.052459230890927,"['JUN', 'CDKN1A', 'NOTCH1', 'WNT2B', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'PIK3CD', 'WNT7A', 'FOS', 'IGF1R', 'GADD45G', 'NFKB2', 'SFRP4', 'FGF9', 'HES1', 'HES5']",0.10699621822740313,0,0,19
25,p53 transcriptional gene network WP4963,0.006917823924021617,2.672273236282195,13.290962525917381,"['BTG2', 'CDKN1A', 'NOTCH1', 'GLS2', 'GADD45A', 'SESN1', 'CCNG1', 'FAS', 'SAT1', 'PML', 'ICAM1']",0.1394633303082758,0,0,11
26,Small cell lung cancer WP4658,0.007371491566327191,2.3099402730375425,11.34211906710013,"['LAMA5', 'CDKN1A', 'LAMA2', 'GADD45B', 'ITGA3', 'GADD45A', 'LAMA3', 'FN1', 'PIK3CD', 'LAMB1', 'GADD45G', 'CCNE2', 'COL4A1', 'RXRG']",0.14032229236875465,0,0,14
27,IL-4 signaling pathway WP395,0.007590094638999904,2.7963306534735106,13.648641657861889,"['SOCS3', 'CEBPB', 'NFIL3', 'IRS1', 'SHC1', 'INPP5D', 'PIK3CD', 'FLNA', 'IRS2', 'FOS']",0.14032229236875465,0,0,10
28,Peptide GPCRs WP24,0.007795682909375258,7.363790186125211,35.74520112875168,"['OXTR', 'EDNRA', 'TAC4', 'NTSR2']",0.14032229236875465,0,0,4
29,miRNA regulation of DNA damage response WP1530,0.008101312444141168,2.6035133660665575,12.537815340307667,"['CDKN1A', 'CCND3', 'CCNE2', 'GADD45B', 'GADD45A', 'SESN1', 'CCNG1', 'TNFRSF10B', 'FAS', 'PML', 'GADD45G']",0.14079522316714305,0,0,11
30,Selenium Micronutrient Network WP15,0.008979000731901382,2.7138355342136853,12.789945064008144,"['SERPINA3', 'SELENOM', 'HBB', 'SOD2', 'SEPHS2', 'LDLR', 'SOD3', 'ICAM1', 'SELENOH', 'NFKB2']",0.15084721229594322,0,0,10
31,Endochondral Ossification with Skeletal Dysplasias WP4808,0.009801890824251225,2.8624498286116076,13.239345614331462,"['HMGCS1', 'ADAMTS1', 'SERPINH1', 'COL10A1', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.1543797804819568,0,0,9
32,Endochondral Ossification WP474,0.009801890824251225,2.8624498286116076,13.239345614331462,"['HMGCS1', 'ADAMTS1', 'SERPINH1', 'COL10A1', 'SLC38A2', 'FGFR3', 'IGF1R', 'DDR2', 'VEGFA']",0.1543797804819568,0,0,9
33,miR-509-3p alteration of YAP1/ECM axis WP3967,0.011993023501456392,6.135927805978567,27.141848197153916,"['EDNRA', 'PBX3', 'FN1', 'TEAD3']",0.17544148097058446,0,0,4
34,NOTCH1 regulation of endothelial cell calcification WP3413,0.011993023501456392,6.135927805978567,27.141848197153916,"['NOTCH1', 'SAT1', 'FGFR3', 'VEGFA']",0.17544148097058446,0,0,4
35,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.012584932614360965,1.6487425168751424,7.213668948667147,"['LAMA5', 'CDKN1A', 'CRTC2', 'CSF1', 'LAMA2', 'CAB39L', 'IRS1', 'LAMA3', 'PIK3CD', 'IRS2', 'PIK3C2A', 'IGF1R', 'GNG3', 'FGF9', 'IFNAR2', 'SREBF1', 'HSP90AA1', 'ITGA3', 'EGF', 'HGF', 'RPS6', 'FN1', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'COL4A1', 'FGFR3']",0.17544148097058446,0,0,29
36,Oncostatin M Signaling Pathway WP2374,0.012607447960896087,2.4168794326241136,10.570143726500524,"['SOCS3', 'EGR1', 'CEBPB', 'IRS1', 'SHC1', 'RPS6', 'FOS', 'OSMR', 'JUNB', 'LDLR', 'VEGFA']",0.17544148097058446,0,0,11
37,Oxidative Stress WP408,0.01322773070809962,3.6847457627118643,15.938146128894576,"['NQO1', 'MGST1', 'FOS', 'SOD2', 'JUNB', 'SOD3']",0.17544148097058446,0,0,6
38,Type II interferon signaling (IFNG) WP619,0.01322773070809962,3.6847457627118643,15.938146128894576,"['SOCS3', 'CIITA', 'HLA-B', 'GBP1', 'ICAM1', 'PSMB9']",0.17544148097058446,0,0,6
39,IL-18 signaling pathway WP4754,0.01400512292430454,1.6836990595611285,7.186586731107366,"['BTG2', 'CEBPB', 'NRN1', 'EPB41', 'HSPB8', 'RGS16', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'SOCS3', 'TMSB4X', 'NFKBIZ', 'RPS11', 'JUN', 'FN1', 'IL18', 'FOS', 'VEGFA', 'NFKB2', 'TNFRSF1A', 'ACTA2', 'KITLG', 'FAS', 'KIFC3', 'PTPN7', 'ARF6']",0.1809892808679356,0,0,26
40,Complement Activation WP545,0.015069845246892024,9.198647506339814,38.588873933780974,"['C3', 'C1S', 'C1R']",0.1827167207800289,0,0,3
41,Transcriptional cascade regulating adipogenesis WP4211,0.015069845246892024,9.198647506339814,38.588873933780974,"['SREBF1', 'CEBPB', 'CEBPD']",0.1827167207800289,0,0,3
42,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.015766422412664134,4.1852051420214,17.368068830918478,"['NQO1', 'JUN', 'SRXN1', 'FOS', 'GCLM']",0.1827167207800289,0,0,5
43,DNA damage response WP707,0.01654730435749071,2.4272735409953454,9.955540268935154,"['CDKN1A', 'CCND3', 'CCNE2', 'GADD45B', 'GADD45A', 'SESN1', 'TNFRSF10B', 'FAS', 'PML', 'GADD45G']",0.1827167207800289,0,0,10
44,Aryl Hydrocarbon Receptor Pathway WP2873,0.016710910372677464,3.4541313559322036,14.133246669197735,"['NQO1', 'HSP90AA1', 'JUN', 'MGST1', 'HES1', 'JUNB']",0.1827167207800289,0,0,6
45,Vitamin A and carotenoid metabolism WP716,0.016710910372677464,3.4541313559322036,14.133246669197735,"['RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG', 'RLBP1']",0.1827167207800289,0,0,6
46,Cancer immunotherapy by PD-1 blockade WP4585,0.01740159245524085,5.258883248730965,21.304753931819533,"['JUN', 'NFATC2', 'NFATC1', 'PDCD1LG2']",0.1827167207800289,0,0,4
47,Differentiation of white and brown adipocyte WP2895,0.01740159245524085,5.258883248730965,21.304753931819533,"['SMAD1', 'CEBPB', 'SMAD9', 'SLC7A10']",0.1827167207800289,0,0,4
48,Fatty acid transporters WP5061,0.01740159245524085,5.258883248730965,21.304753931819533,"['FABP3', 'FABP5', 'ACSL6', 'DBI']",0.1827167207800289,0,0,4
49,DNA damage response (only ATM dependent) WP710,0.020788919871321917,1.9884484116566028,7.701927092437502,"['JUN', 'CDKN1A', 'WNT2B', 'IRS1', 'SHC1', 'WNT7B', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'SOD2', 'NFKB2', 'CCND3', 'BCL6', 'LDLR']",0.21382889010502545,0,0,14
50,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.02178363863620329,2.4403768304263083,9.338336491720286,"['BEX3', 'SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'NRG1', 'YBX3', 'ETS1']",0.2170507137185942,0,0,9
51,Osteoblast differentiation WP4787,0.02196346507866727,2.0335804181657924,7.764972393970993,"['HES6', 'SMAD1', 'NOTCH1', 'WNT2B', 'FZD4', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'PIK3C2A', 'FGF9', 'PRKCQ', 'FGFR3']",0.2170507137185942,0,0,13
52,Ovarian infertility WP34,0.026232006153954022,3.540676089363642,12.890805006399018,"['EGR1', 'CEBPB', 'MSH5', 'INHA', 'SYNE2']",0.25424867503063125,0,0,5
53,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.027045545461483213,18.385135135135137,66.37462093451084,"['NRP1', 'VEGFA']",0.25718782853938754,0,0,2
54,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.027895485993716274,2.6868461973423807,9.617002788560395,"['CDKN1A', 'HSP90AA1', 'JUN', 'FAS', 'FOS', 'JUNB', 'TNFRSF1A']",0.26035786927468524,0,0,7
55,Transcription factor regulation in adipogenesis WP3599,0.032176727257121444,4.089490505734161,14.053582557800635,"['CEBPB', 'CEBPD', 'IRS1', 'IRS2']",0.29485582795616744,0,0,4
56,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.032779073676357094,2.5791348600508908,8.815392591331927,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'RPS6KA2', 'FOS', 'JUNB']",0.2950116630872138,0,0,7
57,Apoptosis Modulation and Signaling WP1772,0.03373783793608516,2.0286808510638297,6.8754738524317665,"['JUN', 'CASP6', 'IL1R1', 'BAG3', 'TNFRSF10B', 'FAS', 'TNFRSF11B', 'FOS', 'MAP3K14', 'TNFRSF1A', 'HSPA1A']",0.2983135143822267,0,0,11
58,Nonalcoholic fatty liver disease WP4396,0.03600893826489588,1.6555997477809574,5.503193837152348,"['COX8A', 'SREBF1', 'XBP1', 'JUN', 'NDUFA7', 'IRS1', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'PIK3CD', 'IRS2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX7A1', 'TNFRSF1A', 'SOCS3', 'UQCRQ', 'FAS']",0.31031707827136124,0,0,19
59,Galanin receptor pathway WP4970,0.03632680082938554,5.518174133558749,18.293848102400073,"['CDKN1A', 'FOS', 'VEGFA']",0.31031707827136124,0,0,3
60,PI3K-Akt signaling pathway WP4172,0.0379189284504316,1.5042724825098497,4.922438155519386,"['LAMA5', 'CDKN1A', 'CSF1', 'LAMA2', 'IRS1', 'LAMA3', 'PIK3CD', 'IGF1R', 'CCND3', 'GNG3', 'FGF9', 'IFNAR2', 'HSP90AA1', 'ITGA3', 'EGF', 'HGF', 'RPS6', 'FN1', 'LAMB1', 'OSMR', 'VEGFA', 'EFNA1', 'KITLG', 'CCNE2', 'COL4A1', 'IL7', 'FGFR3']",0.3156280988759395,0,0,27
61,Ferroptosis WP4313,0.03820101990363554,2.4797090102433614,8.095984749963025,"['TFRC', 'ACSL6', 'GCLM', 'SAT1', 'CP', 'SLC39A14', 'FTL']",0.3156280988759395,0,0,7
62,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.03885085711268486,1.908065558362216,6.197444902918732,"['MRAS', 'SHC1', 'EGF', 'HGF', 'RPS6', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1', 'FGFR3', 'IGF1R', 'VEGFA']",0.3158198707224704,0,0,12
63,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.04163608594450857,3.6802030456852792,11.6985854158838,"['ICAM1', 'NFKB2', 'VEGFA', 'TNFRSF1A']",0.32760441758686504,0,0,4
64,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.04176909883727225,2.126527677929547,6.752998051305337,"['IFI27L2', 'JUN', 'PLCG2', 'PLCE1', 'PRKCQ', 'ETS1', 'RXRG', 'TNFRSF1A', 'NFKB2']",0.32760441758686504,0,0,9
65,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.04337015391591578,2.2332664505839377,7.007953881016688,"['SREBF1', 'SQLE', 'HMGCS1', 'SCD', 'MSMO1', 'DHCR24', 'DHCR7', 'HSD17B7']",0.32760441758686504,0,0,8
66,ESC Pluripotency Pathways WP3931,0.04339440464682683,1.8167222093053295,5.699829262182869,"['SMAD1', 'JUN', 'WNT2B', 'FZD4', 'EGF', 'WNT7B', 'GAB1', 'SMAD9', 'PIK3CD', 'WNT7A', 'FOS', 'FGF9', 'FGFR3']",0.32760441758686504,0,0,13
67,The influence of laminopathies on Wnt signaling WP4844,0.04355058725857134,2.630508474576271,8.243571873477528,"['SREBF1', 'CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'HES5']",0.32760441758686504,0,0,6
68,Heart Development WP1591,0.048767455354371395,2.87600550381033,8.68752706774326,"['SMAD1', 'NOTCH1', 'NFATC2', 'NFATC1', 'VEGFA']",0.348124882177259,0,0,5
69,Tryptophan metabolism WP465,0.048767455354371395,2.87600550381033,8.68752706774326,"['WARS', 'MAOB', 'AADAT', 'HAAO', 'DHCR24']",0.348124882177259,0,0,5
70,Focal Adhesion WP306,0.04939486960681272,1.5651074221589092,4.707700253918901,"['LAMA5', 'JUN', 'CAV3', 'LAMA2', 'SHC1', 'ITGA3', 'EGF', 'ACTN1', 'HGF', 'LAMA3', 'FN1', 'PIK3CD', 'LAMB1', 'MYL12A', 'VEGFA', 'IGF1R', 'MYL5', 'CCND3', 'COL4A1', 'FLNA']",0.348124882177259,0,0,20
71,Blood Clotting Cascade WP272,0.0505842577302907,9.191722972972974,27.429157141548064,"['F3', 'KLKB1']",0.348124882177259,0,0,2
72,Cells and molecules involved in local acute inflammatory response  WP4493,0.0505842577302907,9.191722972972974,27.429157141548064,"['C3', 'ICAM1']",0.348124882177259,0,0,2
73,IL1 and megakaryocytes in obesity WP2865,0.05059238159538699,4.598055790363483,13.720388234091818,"['IL1R1', 'IL18', 'ICAM1']",0.348124882177259,0,0,3
74,Cholesterol Biosynthesis Pathway WP197,0.052495021915618424,3.345331487463467,9.858815451818446,"['SQLE', 'HMGCS1', 'MSMO1', 'DHCR7']",0.348124882177259,0,0,4
75,MAPK pathway in congenital thyroid cancer WP4928,0.052495021915618424,3.345331487463467,9.858815451818446,"['GAREM2', 'JUN', 'SHC1', 'FOS']",0.348124882177259,0,0,4
76,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.052495021915618424,3.345331487463467,9.858815451818446,"['SREBF1', 'HMGCS1', 'SCD', 'LDLR']",0.348124882177259,0,0,4
77,Neural Crest Differentiation WP2064,0.05443398868676049,1.9198200113378685,5.588147829142946,"['SMAD1', 'NOTCH1', 'DCT', 'HES1', 'TBX6', 'ETS1', 'FGFR3', 'HES5', 'GFAP', 'NFKB2']",0.3562951986769778,0,0,10
78,Glucocorticoid Receptor Pathway WP2880,0.05540313104179008,2.1052631578947367,6.0907771996339015,"['AKAP13', 'HSP90AA1', 'JUN', 'GADD45B', 'SPINK13', 'SPRY1', 'ANGPTL4', 'NFKB2']",0.35798946211618204,0,0,8
79,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.05819586016379843,2.7065796682771333,7.697353045309669,"['HSP90AA1', 'ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.3712748547158786,0,0,5
80,Apoptosis Modulation by HSP70 WP384,0.0647379009630732,3.0662718556119573,8.39363849851349,"['CASP6', 'FAS', 'TNFRSF1A', 'HSPA1A']",0.3980709611984184,0,0,4
81,Eicosanoid Synthesis WP167,0.06713498353544754,3.940828402366864,10.644374582628128,"['PNPLA3', 'ALOX12', 'PLA2G5']",0.3980709611984184,0,0,3
82,FOXA2 pathway WP5066,0.06713498353544754,3.940828402366864,10.644374582628128,"['SREBF1', 'IRS1', 'IRS2']",0.3980709611984184,0,0,3
83,Hypertrophy Model WP516,0.06713498353544754,3.940828402366864,10.644374582628128,"['IL1R1', 'IL18', 'VEGFA']",0.3980709611984184,0,0,3
84,ID signaling pathway WP53,0.06713498353544754,3.940828402366864,10.644374582628128,"['SREBF1', 'ID3', 'ELK3']",0.3980709611984184,0,0,3
85,Kynurenine Pathway and links to Cellular Senescence WP5044,0.06713498353544754,3.940828402366864,10.644374582628128,"['CDKN1A', 'AADAT', 'HAAO']",0.3980709611984184,0,0,3
86,Aryl Hydrocarbon Receptor Netpath WP2586,0.0680803449345538,2.301059322033898,6.183099943675934,"['NQO1', 'CDKN1A', 'HSP90AA1', 'KLF6', 'PSRC1', 'VEGFA']",0.39898248659319896,0,0,6
87,Mitochondrial CIV Assembly WP4922,0.07772471768397557,2.2088135593220337,5.642595261235351,"['COX8A', 'COA3', 'NDUFA4', 'COX7A2', 'COX14', 'PET117']",0.42860873726902216,0,0,6
88,Monoamine Transport WP727,0.07832862252153383,2.8301444748145257,7.207931361698417,"['IL1R1', 'TNFRSF11B', 'SLC6A1', 'FBXO32']",0.42860873726902216,0,0,4
89,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.07888977697958693,6.127252252252252,15.561404779977313,"['SMAD1', 'SMAD9']",0.42860873726902216,0,0,2
90,Cytokines and Inflammatory Response WP530,0.07888977697958693,6.127252252252252,15.561404779977313,"['CSF1', 'IL7']",0.42860873726902216,0,0,2
91,Liver X receptor pathway WP2874,0.07888977697958693,6.127252252252252,15.561404779977313,"['SREBF1', 'SCD']",0.42860873726902216,0,0,2
92,PTF1A related regulatory pathway WP4147,0.07888977697958693,6.127252252252252,15.561404779977313,"['NOTCH1', 'HES1']",0.42860873726902216,0,0,2
93,Neovascularisation processes WP4331,0.07993893115731762,2.4212308926422748,6.1172211979448505,"['SMAD1', 'KITLG', 'NOTCH1', 'SMAD9', 'NFKB2']",0.42860873726902216,0,0,5
94,Signal transduction through IL1R WP4496,0.07993893115731762,2.4212308926422748,6.1172211979448505,"['JUN', 'IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14']",0.42860873726902216,0,0,5
95,BMP Signaling Pathway in Eyelid Development WP3927,0.0857850228614052,3.4479078613693996,8.467754314298189,"['SMAD1', 'JUN', 'NOTCH1']",0.4457283662077136,0,0,3
96,Leptin Insulin Overlap WP3935,0.0857850228614052,3.4479078613693996,8.467754314298189,"['SOCS3', 'IRS1', 'IRS2']",0.4457283662077136,0,0,3
97,Tryptophan catabolism leading to NAD+ production WP4210,0.0857850228614052,3.4479078613693996,8.467754314298189,"['AADAT', 'HAAO', 'NAMPT']",0.4457283662077136,0,0,3
98,Insulin Signaling WP481,0.08685573816696347,1.4605469865752643,3.5688563745596085,"['EGR1', 'SNAP25', 'XBP1', 'JUN', 'IRS1', 'SHC1', 'GAB1', 'PIK3CD', 'IRS2', 'FOS', 'PIK3C2A', 'IGF1R', 'SOCS3', 'RPS6KA2', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'SH2B2', 'ARF6']",0.4466866534300979,0,0,19
99,Striated Muscle Contraction Pathway WP383,0.0932133807294839,2.6277495769881556,6.235292365778134,"['ACTA2', 'ACTN2', 'TPM2', 'TCAP']",0.4745408473500999,0,0,4
100,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.09425480667332391,1.7632639780184023,4.164394791752876,"['EGR1', 'CCND3', 'JUN', 'APEX1', 'RPS6', 'ADCY2', 'FOS', 'RALGDS', 'IGF1R']",0.4750442256335525,0,0,9
101,Phosphoinositides metabolism WP4971,0.09918475165476665,2.0448210922787196,4.725113259090683,"['INPP5D', 'PLCG2', 'PIK3CD', 'PIP4K2A', 'PLCE1', 'PIK3C2A']",0.4949417310297266,0,0,6
102,Myometrial relaxation and contraction pathways WP289,0.10058056832907498,1.502756841050013,3.451526198646237,"['RGS17', 'OXTR', 'JUN', 'RGS16', 'ADCY2', 'FOS', 'RXFP1', 'RGS4', 'ACTA2', 'GNG3', 'GRK5', 'PRKAR2B', 'PLCG2', 'PRKCQ', 'YWHAH']",0.49698633762601757,0,0,15
103,PPAR signaling pathway WP3942,0.10232828998528348,1.894851070199072,4.3194439578399875,"['FABP3', 'FABP5', 'SCD', 'ACSL6', 'DBI', 'ANGPTL4', 'RXRG']",0.5007131859474065,0,0,7
104,Cysteine and methionine catabolism WP4504,0.10634354482563466,3.0645252183713723,6.867847514461478,"['BHMT', 'ETHE1', 'SQOR']",0.5076644165218281,0,0,3
105,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.10634354482563466,3.0645252183713723,6.867847514461478,"['RPH3AL', 'SYTL4', 'TBC1D10A']",0.5076644165218281,0,0,3
106,Zinc homeostasis WP3529,0.10932345253337103,2.4523406655386353,5.428119557355139,"['SLC30A3', 'SLC39A11', 'SLC30A10', 'SLC39A14']",0.5076644165218281,0,0,4
107,Farnesoid X receptor pathway WP2879,0.1107997734472244,4.595016891891892,10.109177537038795,"['IRS2', 'FKBP5']",0.5076644165218281,0,0,2
108,Insulin signaling in adipocytes (diabetic condition) WP3635,0.1107997734472244,4.595016891891892,10.109177537038795,"['IRS1', 'RPS6']",0.5076644165218281,0,0,2
109,Insulin signaling in adipocytes (normal condition) WP3634,0.1107997734472244,4.595016891891892,10.109177537038795,"['IRS1', 'RPS6']",0.5076644165218281,0,0,2
110,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.1107997734472244,4.595016891891892,10.109177537038795,"['SOCS3', 'CHI3L1']",0.5076644165218281,0,0,2
111,Exercise-induced Circadian Regulation WP410,0.1129642848150897,1.840542832909245,4.013641522622033,"['DNAJA1', 'CEBPB', 'RBPMS', 'PPP1R3C', 'TAB2', 'ERC2', 'ETV6']",0.512918914836083,0,0,7
112,Ebola Virus Pathway on Host WP4217,0.11484878053354523,1.515944187251125,3.2807138886536586,"['CAV3', 'ITGA3', 'ACTN1', 'HLA-B', 'PIK3CD', 'IGF1R', 'HLA-E', 'NFKB2', 'BST2', 'SOCS3', 'NEDD4', 'IRF7', 'FLNA']",0.5168195124009536,0,0,13
113,IL17 signaling pathway WP2112,0.11947183892234417,2.090485720883689,4.441601898056615,"['CEBPB', 'CEBPD', 'IL17RE', 'MAP3K14', 'IL17RB']",0.5296252324198402,0,0,5
114,Calcium Regulation in the Cardiac Cell WP536,0.11983113481762388,1.4548968492965977,3.086813525552595,"['RGS17', 'RGS16', 'CHRM5', 'ATP1A4', 'ADCY2', 'ATP1B2', 'RGS4', 'GNG3', 'PLN', 'GRK5', 'PRKAR2B', 'CAMK4', 'GJA9', 'PRKCQ', 'YWHAH']",0.5296252324198402,0,0,15
115,Head and Neck Squamous Cell Carcinoma WP4674,0.12084702723865401,1.6570093457943926,3.501641480200743,"['CDKN1A', 'NOTCH1', 'SESN1', 'RPS6', 'GAB1', 'FGFR3', 'IGF1R', 'NFKB2', 'VEGFA']",0.5296252324198402,0,0,9
116,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.12304279918111821,1.712322817546492,3.587698190665793,"['CDKN1A', 'JUN', 'DAAM1', 'SHC1', 'FZD4', 'TMSB4X', 'FN1', 'PFN2']",0.5345997481662378,0,0,8
117,Phytochemical activity on NRF2 transcriptional activation WP3,0.12859360280239446,2.7578191039729503,5.656557836881797,"['NQO1', 'CEBPB', 'GCLM']",0.5539416736103145,0,0,3
118,Allograft Rejection WP2328,0.13435807133513822,1.9994109634429187,4.01331139581162,"['C3', 'HLA-B', 'FAS', 'HLA-E', 'VEGFA']",0.5591475687101672,0,0,5
119,Bladder cancer WP2828,0.13435807133513822,1.9994109634429187,4.01331139581162,"['CDKN1A', 'EGF', 'DAPK2', 'FGFR3', 'VEGFA']",0.5591475687101672,0,0,5
120,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.13502080495121344,1.4933007965375937,2.9900756105388093,"['ATP5IF1', 'COX8A', 'NDUFA7', 'UQCRQ', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX7A2', 'UQCR11', 'UQCR10', 'SLC25A5', 'COX7A1']",0.5591475687101672,0,0,12
121,RANKL/RANK signaling pathway WP2018,0.13588917336043282,1.7407330995117254,3.4743563961355033,"['JUN', 'TNFRSF11B', 'NFATC1', 'TAB2', 'FOS', 'ICAM1', 'NFKB2']",0.5591475687101672,0,0,7
122,Notch Signaling WP268,0.13655252446958077,1.8398305084745763,3.6631870710354932,"['LFNG', 'NUMBL', 'NOTCH1', 'DTX3L', 'HES1', 'HES5']",0.5591475687101672,0,0,6
123,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.13767911437135458,1.460077350134115,2.895084529169385,"['NOTCH1', 'WNT2B', 'SHC1', 'FZD4', 'WNT7B', 'EIF5A2', 'FN1', 'PIK3CD', 'WNT7A', 'CLDN11', 'CLDN20', 'COL4A1', 'MMP15']",0.5591475687101672,0,0,13
124,Cell migration and invasion through p75NTR WP4561,0.1448862738991747,2.163431870210013,4.179331018450587,"['EFNA1', 'JUN', 'EFNB3', 'PARD3']",0.5591475687101672,0,0,4
125,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.1448862738991747,2.163431870210013,4.179331018450587,"['HSPB8', 'HSPB1', 'NDRG1', 'RAB11A']",0.5591475687101672,0,0,4
126,miRNAs involvement in the immune response in sepsis WP4329,0.1448862738991747,2.163431870210013,4.179331018450587,"['IRF7', 'TAB2', 'ICAM1', 'NFKB2']",0.5591475687101672,0,0,4
127,Wnt signaling in kidney disease WP4150,0.1448862738991747,2.163431870210013,4.179331018450587,"['WNT2B', 'FZD4', 'WNT7B', 'WNT7A']",0.5591475687101672,0,0,4
128,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.145333991073476,3.675675675675676,7.089352124497505,"['DHCR24', 'DHCR7']",0.5591475687101672,0,0,2
129,Dual hijack model of Vif in HIV infection WP3300,0.145333991073476,3.675675675675676,7.089352124497505,"['ELOB', 'RUNX1']",0.5591475687101672,0,0,2
130,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.145333991073476,3.675675675675676,7.089352124497505,"['HES1', 'VEGFA']",0.5591475687101672,0,0,2
131,Nanoparticle triggered regulated necrosis WP2513,0.145333991073476,3.675675675675676,7.089352124497505,"['TNFRSF1A', 'FTL']",0.5591475687101672,0,0,2
132,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.14814238021547002,1.694768090710236,3.23629768974826,"['SFRP4', 'CCND3', 'JUN', 'WNT2B', 'WIF1', 'WNT7B', 'WNT7A']",0.5656345426408855,0,0,7
133,Prolactin Signaling Pathway WP2037,0.15106230298152537,1.5627835398598933,2.9537592280793232,"['SOCS3', 'JUN', 'IRS1', 'SHC1', 'RPS6KA2', 'RPS6', 'FLNA', 'IRS2', 'FOS']",0.5724466218247277,0,0,9
134,NAD+ metabolism WP3644,0.1523092993798289,2.506877737646968,4.717547718620649,"['NT5E', 'NAMPT', 'CD38']",0.5728648275181625,0,0,3
135,Interferon type I signaling pathways WP585,0.16089461093528068,1.6511602618472847,3.016679241049713,"['IFNAR2', 'SOCS3', 'IRS1', 'RPS6', 'PDCD4', 'PIK3CD', 'IRS2']",0.5884226448358328,0,0,7
136,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.16089461093528068,1.6511602618472847,3.016679241049713,"['IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'FOS', 'MAP3K14']",0.5884226448358328,0,0,7
137,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.1628057297462164,1.408154054460659,2.5560779037846677,"['EGR1', 'SNAP25', 'JUN', 'CEBPB', 'CAV3', 'CHRNA4', 'NFKB2', 'VEGFA', 'PRKAR2B', 'PAH', 'HES1', 'HES5', 'YWHAH']",0.5884226448358328,0,0,13
138,"GPCRs, Other WP117",0.1641508160686153,2.0430532054897537,3.691735163370926,"['EDNRA', 'RXFP1', 'GRM1', 'GPR135']",0.5884226448358328,0,0,4
139,Lung fibrosis WP3624,0.1641508160686153,2.0430532054897537,3.691735163370926,"['CEBPB', 'EGF', 'HGF', 'ATP11A']",0.5884226448358328,0,0,4
140,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.1641508160686153,2.0430532054897537,3.691735163370926,"['P4HA2', 'SERPINH1', 'P3H2', 'TNFRSF11B']",0.5884226448358328,0,0,4
141,IL-3 signaling pathway WP286,0.16461823992431038,1.7245233050847457,3.111257648317197,"['JUN', 'SHC1', 'INPP5D', 'PIK3CD', 'ENPP3', 'FOS']",0.5884226448358328,0,0,6
142,Type 2 papillary renal cell carcinoma WP4241,0.16641059755396803,1.8391193903471634,3.2980874056290848,"['CDKN1A', 'EGLN3', 'COL21A1', 'ELOB', 'VEGFA']",0.5906404307549288,0,0,5
143,Senescence and Autophagy in Cancer WP615,0.1764608171687132,1.4606953892668177,2.533804643856039,"['JUN', 'CDKN1A', 'CEBPB', 'IFI16', 'FN1', 'IRF7', 'COL10A1', 'CXCL14', 'CD44', 'IGF1R']",0.6063678600693388,0,0,10
144,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.1772628764304946,2.297759932375317,3.975403793333679,"['JUN', 'ACTN1', 'PRKCQ']",0.6063678600693388,0,0,3
145,Mitochondrial complex III assembly WP4921,0.1772628764304946,2.297759932375317,3.975403793333679,"['UQCRQ', 'UQCR11', 'UQCR10']",0.6063678600693388,0,0,3
146,Pregnane X receptor pathway WP2876,0.1772628764304946,2.297759932375317,3.975403793333679,"['HSP90AA1', 'CYP3A5', 'CYP3A7']",0.6063678600693388,0,0,3
147,Statin inhibition of cholesterol production WP430,0.1772628764304946,2.297759932375317,3.975403793333679,"['SQLE', 'APOC1', 'LDLR']",0.6063678600693388,0,0,3
148,Biomarkers for urea cycle disorders WP4583,0.18166973585410745,3.0627815315315314,5.22377261075972,"['GLS2', 'GPT']",0.6063678600693388,0,0,2
149,"GPCRs, Class B Secretin-like WP334",0.18166973585410745,3.0627815315315314,5.22377261075972,"['CALCRL', 'ADGRG2']",0.6063678600693388,0,0,2
150,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.18166973585410745,3.0627815315315314,5.22377261075972,"['EGF', 'FN1']",0.6063678600693388,0,0,2
151,RAS and bradykinin pathways in COVID-19 WP4969,0.18166973585410745,3.0627815315315314,5.22377261075972,"['SERPING1', 'KLKB1']",0.6063678600693388,0,0,2
152,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.18685754891196413,9.184810126582278,15.406680624935603,['FAS'],0.6067318691398673,0,0,1
153,COVID-19 adverse outcome pathway WP4891,0.18685754891196413,9.184810126582278,15.406680624935603,['IL7'],0.6067318691398673,0,0,1
154,EV release from cardiac cells and their functional effects WP3297,0.18685754891196413,9.184810126582278,15.406680624935603,['RGS16'],0.6067318691398673,0,0,1
155,let-7 inhibition of ES cell reprogramming WP3299,0.18685754891196413,9.184810126582278,15.406680624935603,['EGR1'],0.6067318691398673,0,0,1
156,Kit receptor signaling pathway WP304,0.1877979594956732,1.5703262376135212,2.626195662846871,"['KITLG', 'SHC1', 'INPP5D', 'RPS6', 'FOS', 'JUNB', 'SH2B2']",0.6067318691398673,0,0,7
157,Melanoma WP4685,0.19312502896248618,1.5018190637885036,2.4696175223373875,"['GRM3', 'CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'FOS', 'ETS1', 'GADD45G']",0.6199682458413569,0,0,8
158,Wnt signaling WP428,0.19849460290236703,1.4154892726321298,2.288836767217672,"['SFRP4', 'CCND3', 'JUN', 'WNT2B', 'DAAM1', 'WIF1', 'WNT7B', 'NFATC2', 'WNT7A', 'NFATC1']",0.6331726573594493,0,0,10
159,IL-1 signaling pathway WP195,0.20189512618038297,1.5327961549335596,2.4524844145688407,"['JUN', 'IL1R1', 'IRAK2', 'PELI1', 'TAB2', 'IL1RAP', 'MAP3K14']",0.6361988360961423,0,0,7
160,Microglia Pathogen Phagocytosis Pathway WP3937,0.2032301837529343,2.120814097145458,3.379339183745266,"['PLCG2', 'PIK3CD', 'PIK3C2A']",0.6361988360961423,0,0,3
161,Urea cycle and metabolism of amino groups WP497,0.2032301837529343,2.120814097145458,3.379339183745266,"['ARG2', 'OAT', 'ACY1']",0.6361988360961423,0,0,3
162,Endometrial cancer WP4155,0.20617380910011662,1.471646859083192,2.3237829760252513,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'FOS', 'FGFR3', 'GADD45G']",0.6374944772175385,0,0,8
163,Proteasome Degradation WP183,0.20617380910011662,1.471646859083192,2.3237829760252513,"['PSMD10', 'PSMB6', 'UBE2B', 'NEDD4', 'HLA-B', 'PSMB10', 'HLA-E', 'PSMB9']",0.6374944772175385,0,0,8
164,VEGFA-VEGFR2 Signaling Pathway WP3888,0.20983549024906525,1.1636139417862708,1.816903386948088,"['SHC1', 'EPB41', 'HSPB1', 'NRARP', 'PLA2G5', 'SHB', 'RPL10A', 'ETS1', 'NDRG1', 'APOLD1', 'RPL7', 'ICAM1', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'RPS11', 'TMSB10', 'EGR1', 'JUN', 'HSP90AA1', 'EGR3', 'RPS6', 'FN1', 'GAB1', 'NFATC2', 'NFATC1', 'BMX', 'SOD2', 'F3', 'RAB11A', 'VEGFA', 'DNAJA1', 'P4HA2', 'TXNIP', 'FAS', 'MYH9', 'RPL27', 'RPL26', 'ARF6', 'HSPA1A']",0.6448602871068835,0,0,40
165,Dopamine metabolism WP2436,0.2191204169876904,2.625,3.985101358923536,"['NQO1', 'MAOB']",0.6471195035645236,0,0,2
166,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.2191204169876904,2.625,3.985101358923536,"['GRM3', 'GRM1']",0.6471195035645236,0,0,2
167,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.2191204169876904,2.625,3.985101358923536,"['JUN', 'PRKCQ']",0.6471195035645236,0,0,2
168,Neuroinflammation WP4919,0.2191204169876904,2.625,3.985101358923536,"['JUN', 'FOS']",0.6471195035645236,0,0,2
169,Nicotine Activity on Dopaminergic Neurons WP1602,0.2191204169876904,2.625,3.985101358923536,"['CHRNA4', 'ADCY2']",0.6471195035645236,0,0,2
170,IL-2 signaling pathway WP49,0.21933034471769347,1.6416172734970365,2.4906227591722856,"['SOCS3', 'JUN', 'SHC1', 'RPS6', 'FOS']",0.6471195035645236,0,0,5
171,T-cell receptor (TCR) signaling pathway WP69,0.21955840299510623,1.442657878091814,2.1872670002821977,"['JUN', 'SHC1', 'NFATC2', 'FAS', 'PRKCQ', 'NFATC1', 'FOS', 'MAP3K14']",0.6471195035645236,0,0,8
172,MAPK Signaling Pathway WP382,0.2229260425482537,1.220438454850329,1.8317746401137613,"['JUN', 'PTPRR', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'HSPB1', 'NFATC1', 'FOS', 'NFKB2', 'TNFRSF1A', 'MRAS', 'FGF9', 'FLNA', 'FAS', 'TAB2', 'PTPN7', 'MAP3K6', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.6532251479320922,0,0,22
173,Sleep regulation WP3591,0.22999480702055508,1.9691462383770075,2.8940513682980393,"['OXTR', 'IL18', 'FOS']",0.6700426747882067,0,0,3
174,Nephrotic syndrome WP4758,0.23801286287879161,1.5848637916435517,2.2749619216455472,"['CUBN', 'ITGA3', 'PLCE1', 'MYH9', 'COQ8B']",0.6824814040644342,0,0,5
175,Wnt signaling pathway and pluripotency WP399,0.24690151276645197,1.3568254941014248,1.897881037485867,"['CCND3', 'JUN', 'WNT2B', 'FZD4', 'WNT7B', 'WNT7A', 'PRKCQ', 'LDLR', 'CD44']",0.6824814040644342,0,0,9
176,Retinoblastoma gene in cancer WP2446,0.24724078354584453,1.3879616875420444,1.9395273704701224,"['BARD1', 'CDKN1A', 'CCND3', 'CCNE2', 'RPA3', 'RBP1', 'HMGB2', 'CDC7']",0.6824814040644342,0,0,8
177,Oxidative Damage WP3941,0.24868374827484407,1.670973696354407,2.3252823424358353,"['CDKN1A', 'C1S', 'C1R', 'GADD45A']",0.6824814040644342,0,0,4
178,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.25711677857856213,2.2966638513513513,3.1193860434663123,"['NOTCH1', 'VEGFA']",0.6824814040644342,0,0,2
179,Glutathione metabolism WP100,0.25711677857856213,2.2966638513513513,3.1193860434663123,"['OPLAH', 'GCLM']",0.6824814040644342,0,0,2
180,miRNAs involved in DNA damage response WP1545,0.25711677857856213,2.2966638513513513,3.1193860434663123,"['CDKN1A', 'CCND3']",0.6824814040644342,0,0,2
181,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.25711677857856213,2.2966638513513513,3.1193860434663123,"['IFIH1', 'SAMHD1']",0.6824814040644342,0,0,2
182,Ebstein-Barr virus LMP1 signaling WP262,0.25735109313889104,1.8377007607776839,2.4943369800041415,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.6824814040644342,0,0,3
183,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.25735109313889104,1.8377007607776839,2.4943369800041415,"['UGT8', 'UGCG', 'GALNT16']",0.6824814040644342,0,0,3
184,Prostaglandin Synthesis and Regulation WP98,0.25735109313889104,1.8377007607776839,2.4943369800041415,"['HSD11B1', 'EDNRA', 'S100A6']",0.6824814040644342,0,0,3
185,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.25735109313889104,1.8377007607776839,2.4943369800041415,"['IFIH1', 'IFNAR2', 'IRF7']",0.6824814040644342,0,0,3
186,Urea cycle and associated pathways WP4595,0.25735109313889104,1.8377007607776839,2.4943369800041415,"['OAT', 'GLS2', 'GPT']",0.6824814040644342,0,0,3
187,White fat cell differentiation WP4149,0.25735109313889104,1.8377007607776839,2.4943369800041415,"['SREBF1', 'CEBPB', 'CEBPD']",0.6824814040644342,0,0,3
188,Non-small cell lung cancer WP4255,0.2614894468144742,1.3621329308935421,1.827112470660895,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PLCG2', 'PIK3CD', 'RXRG', 'GADD45G']",0.6824814040644342,0,0,8
189,Apoptosis WP254,0.2618881645318948,1.39899325146587,1.8744239273326817,"['JUN', 'CASP6', 'IRF7', 'TNFRSF10B', 'FAS', 'IGF1R', 'TNFRSF1A']",0.6824814040644342,0,0,7
190,Benzene metabolism WP3891,0.26676356468391577,4.591983122362869,6.067812234439219,['NQO1'],0.6824814040644342,0,0,1
191,Composition of Lipid Particles WP3601,0.26676356468391577,4.591983122362869,6.067812234439219,['LDLR'],0.6824814040644342,0,0,1
192,Drug Induction of Bile Acid Pathway WP2289,0.26676356468391577,4.591983122362869,6.067812234439219,['SLC51A'],0.6824814040644342,0,0,1
193,Hypothetical Craniofacial Development Pathway WP3655,0.26676356468391577,4.591983122362869,6.067812234439219,['ARHGAP29'],0.6824814040644342,0,0,1
194,Macrophage markers WP4146,0.26676356468391577,4.591983122362869,6.067812234439219,['F3'],0.6824814040644342,0,0,1
195,Metabolism of alpha-linolenic acid WP4586,0.26676356468391577,4.591983122362869,6.067812234439219,['ALOX12'],0.6824814040644342,0,0,1
196,Steroid Biosynthesis WP496,0.26676356468391577,4.591983122362869,6.067812234439219,['HSD17B7'],0.6824814040644342,0,0,1
197,Tamoxifen metabolism WP691,0.26676356468391577,4.591983122362869,6.067812234439219,['CYP3A5'],0.6824814040644342,0,0,1
198,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2711553840950166,1.5981755315235784,2.0857201522395608,"['IFIH1', 'IFNAR2', 'JUN', 'FOS']",0.6867452943913988,0,0,4
199,Neural Crest Cell Migration during Development WP4564,0.2711553840950166,1.5981755315235784,2.0857201522395608,"['JUN', 'PIK3CD', 'FOS', 'EPHB1']",0.6867452943913988,0,0,4
200,Pyrimidine metabolism WP4022,0.2736133649444162,1.3135089209855566,1.7023591114971188,"['NT5C', 'POLE4', 'POLD4', 'ENTPD3', 'NME3', 'ENPP3', 'POLR2I', 'POLR2K', 'POLR2L']",0.6895056796599288,0,0,9
201,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.27762735830379426,1.369101113457131,1.7544695369820187,"['SFRP4', 'CCND3', 'JUN', 'WNT2B', 'WIF1', 'WNT7B', 'WNT7A']",0.6961402417169766,0,0,7
202,7-oxo-C and 7beta-HC pathways WP5064,0.28510627460318405,1.7226859678782755,2.1617870358144344,"['HSD11B1', 'DBP', 'DHCR7']",0.7009442068292915,0,0,3
203,PKC-gamma calcium signaling pathway in ataxia WP4760,0.28510627460318405,1.7226859678782755,2.1617870358144344,"['GNA14', 'GRM1', 'GRIA4']",0.7009442068292915,0,0,3
204,TYROBP causal network in microglia WP3945,0.28510627460318405,1.7226859678782755,2.1617870358144344,"['C3', 'IL18', 'IL13RA1']",0.7009442068292915,0,0,3
205,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.28510627460318405,1.7226859678782755,2.1617870358144344,"['WIF1', 'ZBTB16', 'PML']",0.7009442068292915,0,0,3
206,GDNF/RET signaling axis WP4830,0.2951905008725891,2.0412912912912913,2.4906496542747165,"['IFT27', 'SPRY1']",0.7077069806566056,0,0,2
207,GPR40 Pathway WP3958,0.2951905008725891,2.0412912912912913,2.4906496542747165,"['PLCG2', 'PLCE1']",0.7077069806566056,0,0,2
208,Imatinib and Chronic Myeloid Leukemia WP3640,0.2951905008725891,2.0412912912912913,2.4906496542747165,"['GADD45A', 'PIM1']",0.7077069806566056,0,0,2
209,Serotonin and anxiety WP3947,0.2951905008725891,2.0412912912912913,2.4906496542747165,"['FOS', 'GRM1']",0.7077069806566056,0,0,2
210,TP53 network WP1742,0.2951905008725891,2.0412912912912913,2.4906496542747165,"['CDKN1A', 'GADD45A']",0.7077069806566056,0,0,2
211,TGF-beta Receptor Signaling WP560,0.29628208912409487,1.435885901778154,1.7466737484262544,"['SMAD1', 'JUN', 'EGF', 'SMAD9', 'FOS']",0.7077069806566056,0,0,5
212,DNA Mismatch Repair WP531,0.31308186329015564,1.62120232708468,1.8826869884164859,"['POLE4', 'POLD4', 'RPA3']",0.7315816434660466,0,0,3
213,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.31308186329015564,1.62120232708468,1.8826869884164859,"['CDKN1A', 'FGF9', 'FGFR3']",0.7315816434660466,0,0,3
214,Unfolded protein response WP4925,0.31308186329015564,1.62120232708468,1.8826869884164859,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.7315816434660466,0,0,3
215,TNF-alpha signaling pathway WP231,0.3151073306204811,1.2534563991658298,1.4475440523881709,"['HSP90AA1', 'JUN', 'OTUD7B', 'TAB2', 'PYGL', 'RFFL', 'MAP3K14', 'TNFRSF1A', 'NFKB2']",0.7315816434660466,0,0,9
216,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3162311545949798,1.3922459138377852,1.6028674247872483,"['JUN', 'NFATC2', 'PRKCQ', 'FOS', 'MAP3K14']",0.7315816434660466,0,0,5
217,Cori Cycle WP1946,0.33295988714663016,1.8369932432432432,2.0202025593129966,"['GPT', 'PFKP']",0.7315816434660466,0,0,2
218,Pyrimidine metabolism and related diseases WP4225,0.33295988714663016,1.8369932432432432,2.0202025593129966,"['NT5C', 'GLS2']",0.7315816434660466,0,0,2
219,Gastrin signaling pathway WP4659,0.33628082677153587,1.2093850698174007,1.3179983394591588,"['EGR1', 'JUN', 'CDKN1A', 'IRS1', 'SHC1', 'RPS6', 'PRKCQ', 'FOS', 'CD44', 'VEGFA']",0.7315816434660466,0,0,10
220,FTO Obesity Variant Mechanism WP3407,0.3388233269847994,3.061040787623066,3.3128924083266007,['ARID5B'],0.7315816434660466,0,0,1
221,GABA metabolism (aka GHB) WP4157,0.3388233269847994,3.061040787623066,3.3128924083266007,['ADHFE1'],0.7315816434660466,0,0,1
222,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3388233269847994,3.061040787623066,3.3128924083266007,['OPLAH'],0.7315816434660466,0,0,1
223,Irinotecan pathway WP229,0.3388233269847994,3.061040787623066,3.3128924083266007,['CYP3A5'],0.7315816434660466,0,0,1
224,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.3388233269847994,3.061040787623066,3.3128924083266007,['CDKN1A'],0.7315816434660466,0,0,1
225,Osteoblast Signaling WP322,0.3388233269847994,3.061040787623066,3.3128924083266007,['TNFRSF11B'],0.7315816434660466,0,0,1
226,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.3388233269847994,3.061040787623066,3.3128924083266007,['VEGFA'],0.7315816434660466,0,0,1
227,Somatic sex determination WP4814,0.3388233269847994,3.061040787623066,3.3128924083266007,['FGF9'],0.7315816434660466,0,0,1
228,The alternative pathway of fetal androgen synthesis WP4524,0.3388233269847994,3.061040787623066,3.3128924083266007,['HSD17B6'],0.7315816434660466,0,0,1
229,CAMKK2  Pathway WP4874,0.34014932639878565,1.4133801900299363,1.5241475905480995,"['FIS1', 'CAMK4', 'NFATC2', 'ICAM1']",0.7315816434660466,0,0,4
230,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.34014932639878565,1.4133801900299363,1.5241475905480995,"['IRS1', 'FBXO32', 'IGF1R', 'TNFRSF1A']",0.7315816434660466,0,0,4
231,Neural Crest Cell Migration in Cancer WP4565,0.34014932639878565,1.4133801900299363,1.5241475905480995,"['JUN', 'PIK3CD', 'FOS', 'EPHB1']",0.7315816434660466,0,0,4
232,EPO Receptor Signaling WP581,0.34111445677484314,1.5309946463792619,1.6466417068946062,"['SHC1', 'IRS1', 'IRS2']",0.7315816434660466,0,0,3
233,NRF2-ARE regulation WP4357,0.34111445677484314,1.5309946463792619,1.6466417068946062,"['NQO1', 'CEBPB', 'GCLM']",0.7315816434660466,0,0,3
234,SARS-CoV-2 mitochondrial interactions WP5038,0.34111445677484314,1.5309946463792619,1.6466417068946062,"['IFIH1', 'IRF7', 'NFKB2']",0.7315816434660466,0,0,3
235,TLR4 Signaling and Tolerance WP3851,0.34111445677484314,1.5309946463792619,1.6466417068946062,"['INPP5D', 'IRF7', 'TAB2']",0.7315816434660466,0,0,3
236,Ectoderm Differentiation WP2858,0.3471016195571893,1.173402443002646,1.2416213506647573,"['CLDN11', 'TRPM2', 'TSC22D1', 'FZD4', 'ZBTB16', 'BOC', 'PIM1', 'RHPN1', 'HMGB2', 'TNFRSF11B', 'NFATC1', 'KIFC3']",0.7381401529823772,0,0,12
237,TGF-beta Signaling Pathway WP366,0.3471016195571893,1.173402443002646,1.2416213506647573,"['JUN', 'CDKN1A', 'KLF6', 'PARD6A', 'STAMBPL1', 'SHC1', 'LIMK2', 'FN1', 'FOS', 'ETS1', 'JUNB', 'PML']",0.7381401529823772,0,0,12
238,Glioblastoma signaling pathways WP2261,0.35106628554331487,1.2252405206564798,1.2825575486809644,"['CDKN1A', 'IRS1', 'GAB1', 'PLCG2', 'PIK3CD', 'PRKCQ', 'PIK3C2A', 'IGF1R']",0.743434487032902,0,0,8
239,Cytosolic DNA-sensing pathway WP4655,0.356545412599851,1.3124470787468248,1.3535183548996486,"['RNF125', 'IL18', 'IRF7', 'POLR2K', 'POLR2L']",0.7491532618178972,0,0,5
240,Signaling of Hepatocyte Growth Factor Receptor WP313,0.36336172855472076,1.360907438741618,1.377723414610755,"['JUN', 'HGF', 'GAB1', 'FOS']",0.7491532618178972,0,0,4
241,Circadian rhythm related genes WP3594,0.36628009773964215,1.1387236098945905,1.1436849647788918,"['EGR1', 'SREBF1', 'JUN', 'EGR3', 'CARTPT', 'PML', 'CIART', 'DBP', 'NFIL3', 'NOCT', 'NAMPT', 'ID3', 'FAS', 'RPS27A']",0.7491532618178972,0,0,14
242,B Cell Receptor Signaling Pathway WP23,0.3664333219495882,1.2050432798018313,1.2097895911570424,"['JUN', 'BCL6', 'SHC1', 'INPP5D', 'PLCG2', 'GAB1', 'NFATC2', 'ETS1']",0.7491532618178972,0,0,8
243,Notch Signaling Pathway Netpath WP61,0.36766243421370054,1.2528120184899847,1.2535512529013513,"['HES6', 'CDKN1A', 'NUMBL', 'NOTCH1', 'HES1', 'HES5']",0.7491532618178972,0,0,6
244,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.3690560779436968,1.450282511011256,1.445651285786096,"['RAB13', 'NDRG1', 'TEAD3']",0.7491532618178972,0,0,3
245,Airway smooth muscle cell contraction WP4962,0.37011738530288973,1.6698402948402948,1.6597128238018681,"['PPP1R14A', 'CD38']",0.7491532618178972,0,0,2
246,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.37011738530288973,1.6698402948402948,1.6597128238018681,"['EGF', 'HSPB1']",0.7491532618178972,0,0,2
247,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.37011738530288973,1.6698402948402948,1.6597128238018681,"['FGF9', 'GADD45G']",0.7491532618178972,0,0,2
248,miRNA targets in ECM and membrane receptors WP2911,0.37011738530288973,1.6698402948402948,1.6597128238018681,"['COL4A1', 'FN1']",0.7491532618178972,0,0,2
249,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.37011738530288973,1.6698402948402948,1.6597128238018681,"['NQO1', 'FN1']",0.7491532618178972,0,0,2
250,ErbB signaling pathway WP673,0.37220918668106057,1.181393372982158,1.1675701879811968,"['CDKN1A', 'JUN', 'NRG4', 'SHC1', 'EGF', 'GAB1', 'PLCG2', 'PIK3CD', 'NRG1']",0.7503114870423313,0,0,9
251,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.37679317962747844,1.2758726126634679,1.2453267387572515,"['SMAD1', 'JUN', 'EGF', 'SMAD9', 'FOS']",0.7503114870423313,0,0,5
252,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3858529350254135,1.224858757062147,1.166431744331362,"['LAMA5', 'CDKN1A', 'NOTCH1', 'ITGA3', 'PLCE1', 'MYH9']",0.7503114870423313,0,0,6
253,Hepatitis C and Hepatocellular Carcinoma WP3646,0.3865381886553679,1.3121827411167513,1.2472619875701474,"['CDKN1A', 'JUN', 'CD44', 'VEGFA']",0.7503114870423313,0,0,4
254,IL-5 signaling pathway WP127,0.3865381886553679,1.3121827411167513,1.2472619875701474,"['JUN', 'SHC1', 'RPS6', 'FOS']",0.7503114870423313,0,0,4
255,Metapathway biotransformation Phase I and II WP702,0.38666156079322567,1.1646463316859526,1.106653336508568,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'CHST6', 'CHST7', 'MGST1', 'KCNAB1', 'CYP3A5', 'CYP3A7']",0.7503114870423313,0,0,9
256,Regulation of toll-like receptor signaling pathway WP1449,0.38666156079322567,1.1646463316859526,1.106653336508568,"['IFNAR2', 'JUN', 'IRAK2', 'IRF7', 'PELI1', 'PIK3CD', 'TAB2', 'FOS', 'NFKB2']",0.7503114870423313,0,0,9
257,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.3962985632617445,1.1250912630810417,1.041370301652596,"['SLCO1C1', 'SREBF1', 'IRS1', 'SHC1', 'SCD', 'RPS6KA2', 'TRIP10', 'PIK3CD', 'IRS2', 'MAP3K6', 'PIK3C2A', 'MAP3K14']",0.7503114870423313,0,0,12
258,Oxidation by Cytochrome P450 WP43,0.3967741477208367,1.3776415891800506,1.2734754327009212,"['CYP39A1', 'CYP3A5', 'CYP3A7']",0.7503114870423313,0,0,3
259,G1 to S cell cycle control WP45,0.39702725451994253,1.241275144746779,1.146628348745279,"['CDKN1A', 'CCND3', 'CCNE2', 'GADD45A', 'RPA3']",0.7503114870423313,0,0,5
260,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.40380669667820696,2.2955696202531644,2.081666122434677,['COX8A'],0.7503114870423313,0,0,1
261,Bile acids synthesis and enterohepatic circulation  WP4389,0.40380669667820696,2.2955696202531644,2.081666122434677,['LDLR'],0.7503114870423313,0,0,1
262,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.40380669667820696,2.2955696202531644,2.081666122434677,['HSD11B1'],0.7503114870423313,0,0,1
263,Estrogen metabolism WP697,0.40380669667820696,2.2955696202531644,2.081666122434677,['NQO1'],0.7503114870423313,0,0,1
264,miR-517 relationship with ARCN1 and USP1 WP3596,0.40380669667820696,2.2955696202531644,2.081666122434677,['CDKN1A'],0.7503114870423313,0,0,1
265,NAD Biosynthesis II (from tryptophan) WP2485,0.40380669667820696,2.2955696202531644,2.081666122434677,['HAAO'],0.7503114870423313,0,0,1
266,Role of Osx and miRNAs in tooth development WP3971,0.40380669667820696,2.2955696202531644,2.081666122434677,['NOTCH1'],0.7503114870423313,0,0,1
267,SARS-CoV-2 and COVID-19 Pathway WP4846,0.40380669667820696,2.2955696202531644,2.081666122434677,['NRP1'],0.7503114870423313,0,0,1
268,Serotonin Transporter Activity WP1455,0.40380669667820696,2.2955696202531644,2.081666122434677,['IL1R1'],0.7503114870423313,0,0,1
269,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.40380669667820696,2.2955696202531644,2.081666122434677,['IGF1R'],0.7503114870423313,0,0,1
270,Vitamin D Metabolism WP1531,0.40380669667820696,2.2955696202531644,2.081666122434677,['DHCR7'],0.7503114870423313,0,0,1
271,ERK Pathway in Huntington's Disease WP3853,0.40641872214792946,1.5305461711711712,1.378059869573309,"['EGF', 'GRM1']",0.7503114870423313,0,0,2
272,Nanomaterial induced apoptosis WP2507,0.40641872214792946,1.5305461711711712,1.378059869573309,"['CASP6', 'FAS']",0.7503114870423313,0,0,2
273,SARS coronavirus and innate immunity WP4912,0.40641872214792946,1.5305461711711712,1.378059869573309,"['IFIH1', 'IFNAR2']",0.7503114870423313,0,0,2
274,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.40904587527937075,1.1690955355077493,1.0450871926337837,"['CDKN1A', 'JUN', 'GADD45B', 'GADD45A', 'FOS', 'RALGDS', 'GADD45G']",0.750687533166209,0,0,7
275,Fas ligand pathway and stress induction of heat shock proteins WP314,0.40960133258076875,1.2668183674660132,1.1307252761222861,"['JUN', 'CASP6', 'HSPB1', 'FAS']",0.750687533166209,0,0,4
276,Ras signaling WP4223,0.41178023906876215,1.0993844987019048,0.9754459064357459,"['SHC1', 'GAB1', 'PIK3CD', 'PLA2G5', 'ETS1', 'IGF1R', 'GNG3', 'MRAS', 'RASA4', 'PLCG2', 'PLCE1', 'RALGDS', 'FGFR3', 'ARF6']",0.75194652351687,0,0,14
277,MET in type 1 papillary renal cell carcinoma WP4205,0.42218794388489544,1.1725207356653444,1.0110701405496523,"['CDKN1A', 'JUN', 'HGF', 'GAB1', 'PIK3CD', 'ETS1']",0.7634721157618811,0,0,6
278,16p11.2 distal deletion syndrome WP4950,0.4241511754232673,1.311918850380389,1.1251873288159608,"['C3', 'PLN', 'NFATC2']",0.7634721157618811,0,0,3
279,Oxysterols derived from cholesterol WP4545,0.4241511754232673,1.311918850380389,1.1251873288159608,"['CYP39A1', 'DBP', 'DHCR7']",0.7634721157618811,0,0,3
280,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4241511754232673,1.311918850380389,1.1251873288159608,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.7634721157618811,0,0,3
281,Pancreatic adenocarcinoma pathway WP4263,0.4282200736242077,1.1304688520308215,0.9587710099278838,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'RALGDS', 'VEGFA', 'GADD45G']",0.7680530857886145,0,0,8
282,Constitutive Androstane Receptor Pathway WP2875,0.4416734545637322,1.4126819126819128,1.1544217067076576,"['HSP90AA1', 'CYP3A5']",0.7861868252953012,0,0,2
283,Purinergic signaling WP4900,0.4416734545637322,1.4126819126819128,1.1544217067076576,"['P2RY12', 'P2RY14']",0.7861868252953012,0,0,2
284,Male infertility WP4673,0.4436268889904662,1.1132376395534291,0.9048077259038616,"['NQO1', 'BHMT', 'UBE2B', 'MSH5', 'PON1', 'FAS', 'SOD2', 'SOD3']",0.7861868252953012,0,0,8
285,Cell cycle WP179,0.4445699309705572,1.102124044180119,0.8934345545010691,"['CCND3', 'CDKN1A', 'CCNE2', 'GADD45B', 'GADD45A', 'CDC7', 'ANAPC11', 'GADD45G', 'YWHAH']",0.7861868252953012,0,0,9
286,Resistin as a regulator of inflammation WP4481,0.45108423539239284,1.2521709060170598,0.9968547386137958,"['PLCG2', 'PIK3CD', 'PLCE1']",0.7873434485308269,0,0,3
287,Aspirin and miRNAs WP4707,0.4624080570736603,1.8362869198312237,1.4163419419268601,['VEGFA'],0.7873434485308269,0,0,1
288,Biogenic Amine Synthesis WP550,0.4624080570736603,1.8362869198312237,1.4163419419268601,['PAH'],0.7873434485308269,0,0,1
289,Caloric restriction and aging WP4191,0.4624080570736603,1.8362869198312237,1.4163419419268601,['NAMPT'],0.7873434485308269,0,0,1
290,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.4624080570736603,1.8362869198312237,1.4163419419268601,['CEBPB'],0.7873434485308269,0,0,1
291,Genes targeted by miRNAs in adipocytes WP1992,0.4624080570736603,1.8362869198312237,1.4163419419268601,['TMSB4X'],0.7873434485308269,0,0,1
292,LDLRAD4 and what we know about it WP4904,0.4624080570736603,1.8362869198312237,1.4163419419268601,['NEDD4'],0.7873434485308269,0,0,1
293,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.4624080570736603,1.8362869198312237,1.4163419419268601,['LDLR'],0.7873434485308269,0,0,1
294,"Phase I biotransformations, non P450 WP136",0.4624080570736603,1.8362869198312237,1.4163419419268601,['PON1'],0.7873434485308269,0,0,1
295,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4624080570736603,1.8362869198312237,1.4163419419268601,['ICAM1'],0.7873434485308269,0,0,1
296,Urea cycle and related diseases WP4571,0.4624080570736603,1.8362869198312237,1.4163419419268601,['GLS2'],0.7873434485308269,0,0,1
297,G Protein Signaling Pathways WP35,0.47423575623368286,1.0802956156995904,0.8059553056115175,"['AKAP13', 'GNA14', 'AKAP10', 'GNG3', 'PRKAR2B', 'PRKCQ', 'ADCY2', 'PDE8B']",0.7890232158786026,0,0,8
298,Cardiac Progenitor Differentiation WP2406,0.475736763913962,1.3116554054054055,0.9744164641742212,"['NOTCH1', 'NRG1']",0.7890232158786026,0,0,2
299,Gastric Cancer Network 1 WP2361,0.475736763913962,1.3116554054054055,0.9744164641742212,"['NOTCH1', 'GATD3A']",0.7890232158786026,0,0,2
300,Mitochondrial Gene Expression WP391,0.475736763913962,1.3116554054054055,0.9744164641742212,"['CAMK4', 'TFB2M']",0.7890232158786026,0,0,2
301,Toll-like Receptor Signaling Pathway WP75,0.47603096880280493,1.101864406779661,0.8178835006248534,"['IFNAR2', 'JUN', 'IRF7', 'PIK3CD', 'TAB2', 'FOS']",0.7890232158786026,0,0,6
302,Hedgehog Signaling Pathway WP4249,0.47742760322165,1.1477368866328257,0.8485709424195916,"['EVC2', 'HHIP', 'GPR161', 'BOC']",0.7890232158786026,0,0,4
303,IL-6 signaling pathway WP364,0.47742760322165,1.1477368866328257,0.8485709424195916,"['SOCS3', 'SHC1', 'GAB1', 'JUNB']",0.7890232158786026,0,0,4
304,GABA receptor Signaling WP4159,0.4774842873868527,1.197618435076629,0.8853083207087841,"['GABRA2', 'GABRA5', 'SLC6A1']",0.7890232158786026,0,0,3
305,Proximal tubule transport WP4917,0.4774842873868527,1.197618435076629,0.8853083207087841,"['SLC13A3', 'SLC1A1', 'SLC3A1']",0.7890232158786026,0,0,3
306,MECP2 and Associated Rett Syndrome WP3584,0.49367083136262624,1.080159521435693,0.7624698265390383,"['CEBPD', 'BCL6', 'RPS6', 'IGF1R', 'FKBP5', 'GRIA4']",0.7920261337867158,0,0,6
307,Integrated breast cancer pathway WP1984,0.4951452211395887,1.0394072835974415,0.7306037278972889,"['BARD1', 'SMAD1', 'ITPKC', 'JUN', 'RASGEF1A', 'IRS1', 'GADD45A', 'FILIP1', 'FAU', 'PML', 'FOSL2', 'VEGFA']",0.7920261337867158,0,0,12
308,Cardiac Hypertrophic Response WP2795,0.4962776988089616,1.0930002822466836,0.7657774558500293,"['EGF', 'NFATC2', 'NRG1', 'MAP3K14', 'TNFRSF1A']",0.7920261337867158,0,0,5
309,Netrin-UNC5B signaling pathway WP4747,0.49938462501236724,1.112854432651387,0.7727424014692229,"['JUN', 'UNC5B', 'INPP5D', 'ICAM1']",0.7920261337867158,0,0,4
310,EGF/EGFR signaling pathway WP437,0.5028441911892838,1.028259385665529,0.7069025347194526,"['JUN', 'PTPRR', 'SHC1', 'EGF', 'LIMK2', 'GAB1', 'FOS', 'PLSCR1', 'RPS6KA2', 'INPP5D', 'NEDD4', 'PLCE1', 'RALGDS', 'ARF6']",0.7920261337867158,0,0,14
311,Base Excision Repair WP4752,0.5032753877866519,1.1476120033812343,0.7879707923733249,"['POLE4', 'POLD4', 'APEX1']",0.7920261337867158,0,0,3
312,Corticotropin-releasing hormone signaling pathway WP2355,0.5075129597804496,1.0535185416927377,0.7145310746730552,"['HSP90AA1', 'IL18', 'PLCG2', 'PRKCQ', 'FOS', 'JUNB', 'FOSL2']",0.7920261337867158,0,0,7
313,Angiogenesis WP1539,0.5085023414533864,1.2240990990990992,0.8278404209439675,"['SMAD1', 'VEGFA']",0.7920261337867158,0,0,2
314,Canonical and non-canonical Notch signaling WP3845,0.5085023414533864,1.2240990990990992,0.8278404209439675,"['NOTCH1', 'HES1']",0.7920261337867158,0,0,2
315,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5085023414533864,1.2240990990990992,0.8278404209439675,"['SHC1', 'FLNA']",0.7920261337867158,0,0,2
316,NAD+ biosynthetic pathways WP3645,0.5085023414533864,1.2240990990990992,0.8278404209439675,"['NAMPT', 'CD38']",0.7920261337867158,0,0,2
317,One-carbon metabolism WP241,0.5085023414533864,1.2240990990990992,0.8278404209439675,"['BHMT', 'GLRX']",0.7920261337867158,0,0,2
318,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.5152537065149391,1.530098452883263,1.0146019580879027,['NFKB2'],0.7920261337867158,0,0,1
319,"Cerebral organic acidurias, including diseases WP4519",0.5152537065149391,1.530098452883263,1.0146019580879027,['ADHFE1'],0.7920261337867158,0,0,1
320,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5152537065149391,1.530098452883263,1.0146019580879027,['CSF1'],0.7920261337867158,0,0,1
321,Glial Cell Differentiation WP2276,0.5152537065149391,1.530098452883263,1.0146019580879027,['GAP43'],0.7920261337867158,0,0,1
322,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5152537065149391,1.530098452883263,1.0146019580879027,['BHMT'],0.7920261337867158,0,0,1
323,Mevalonate pathway WP3963,0.5152537065149391,1.530098452883263,1.0146019580879027,['HMGCS1'],0.7920261337867158,0,0,1
324,Osteoclast Signaling WP12,0.5152537065149391,1.530098452883263,1.0146019580879027,['TNFRSF11B'],0.7920261337867158,0,0,1
325,Serotonin and anxiety-related events WP3944,0.5152537065149391,1.530098452883263,1.0146019580879027,['FOS'],0.7920261337867158,0,0,1
326,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5152537065149391,1.530098452883263,1.0146019580879027,['JUN'],0.7920261337867158,0,0,1
327,Vitamin B12 Disorders WP4271,0.5152537065149391,1.530098452883263,1.0146019580879027,['CUBN'],0.7920261337867158,0,0,1
328,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5154455791310373,1.0674832128862022,0.7074462646163161,"['LAMA2', 'ACTN2', 'ITGA3', 'ACTN1', 'DSC2']",0.7920261337867158,0,0,5
329,Glycogen Synthesis and Degradation WP500,0.5209320812289686,1.08002388772768,0.7043220347330175,"['HKDC1', 'PYGM', 'PYGL', 'GYG2']",0.7956053604224248,0,0,4
330,One-carbon metabolism and related pathways WP3940,0.5209320812289686,1.08002388772768,0.7043220347330175,"['BHMT', 'SOD2', 'GCLM', 'SOD3']",0.7956053604224248,0,0,4
331,Regulation of Actin Cytoskeleton WP51,0.5349844936781878,1.0096595744680852,0.6315597493149057,"['MRAS', 'FGF9', 'EGF', 'ACTN1', 'TMSB4X', 'CHRM5', 'FN1', 'PIP4K2A', 'PIK3CD', 'PIK3C2A', 'FGFR3']",0.8122617897195354,0,0,11
332,Hippo-Merlin Signaling Dysregulation WP4541,0.5391729041990602,1.0198850249740834,0.6300023296982373,"['PPP1R14A', 'PRKAR2B', 'ITGA3', 'FGFR3', 'CD44', 'IGF1R', 'TEAD3']",0.8122617897195354,0,0,7
333,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5398962292778658,1.1474873310810811,0.7072863201167965,"['BCL6', 'H2AFJ']",0.8122617897195354,0,0,2
334,Genes controlling nephrogenesis WP4823,0.5398962292778658,1.1474873310810811,0.7072863201167965,"['ITGA3', 'VEGFA']",0.8122617897195354,0,0,2
335,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5398962292778658,1.1474873310810811,0.7072863201167965,"['TNFRSF10B', 'CYS1']",0.8122617897195354,0,0,2
336,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.545269026920757,1.0198681732580037,0.618525548557602,"['SREBF1', 'SQLE', 'HMGCS1', 'SCD', 'DBI', 'LDLR']",0.8152468347633977,0,0,6
337,ATM Signaling Pathway WP2516,0.5527872368754168,1.0591390857663048,0.6278386860898314,"['CDKN1A', 'JUN', 'GADD45A']",0.8152468347633977,0,0,3
338,PDGFR-beta pathway WP3972,0.5527872368754168,1.0591390857663048,0.6278386860898314,"['JUN', 'SHC1', 'FOS']",0.8152468347633977,0,0,3
339,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.5626376471008588,1.0198345553675503,0.5865267078305968,"['RPS6KA2', 'RPS6', 'PIM1', 'PDCD4']",0.8152468347633977,0,0,4
340,Cancer immunotherapy by CTLA4 blockade WP4582,0.5629085287652031,1.3113924050632912,0.7535760860981586,['PIK3CD'],0.8152468347633977,0,0,1
341,Estrogen Receptor Pathway WP2881,0.5629085287652031,1.3113924050632912,0.7535760860981586,['JUN'],0.8152468347633977,0,0,1
342,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5629085287652031,1.3113924050632912,0.7535760860981586,['PRKCQ'],0.8152468347633977,0,0,1
343,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5629085287652031,1.3113924050632912,0.7535760860981586,['ELOB'],0.8152468347633977,0,0,1
344,Iron metabolism in placenta WP2007,0.5629085287652031,1.3113924050632912,0.7535760860981586,['TFRC'],0.8152468347633977,0,0,1
345,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5629085287652031,1.3113924050632912,0.7535760860981586,['ADCY2'],0.8152468347633977,0,0,1
346,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5629085287652031,1.3113924050632912,0.7535760860981586,['ANAPC11'],0.8152468347633977,0,0,1
347,Thiamine metabolic pathways WP4297,0.5629085287652031,1.3113924050632912,0.7535760860981586,['SLC19A3'],0.8152468347633977,0,0,1
348,Trans-sulfuration pathway WP2333,0.5629085287652031,1.3113924050632912,0.7535760860981586,['GCLM'],0.8152468347633977,0,0,1
349,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5698714985826457,1.0798887122416534,0.6072693533784754,"['RPS6', 'VEGFA']",0.8159523729706064,0,0,2
350,Hippo-Yap signaling pathway WP4537,0.5698714985826457,1.0798887122416534,0.6072693533784754,"['NDRG1', 'TEAD3']",0.8159523729706064,0,0,2
351,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5698714985826457,1.0798887122416534,0.6072693533784754,"['CEBPB', 'ATP2C2']",0.8159523729706064,0,0,2
352,Vitamin D in inflammatory diseases WP4482,0.5698714985826457,1.0798887122416534,0.6072693533784754,"['DUSP1', 'NFATC1']",0.8159523729706064,0,0,2
353,DNA Replication WP466,0.5764136561978973,1.0198177890485582,0.5618479319427342,"['POLD4', 'RPA3', 'CDC7']",0.8229815374610204,0,0,3
354,Hepatitis B infection WP4666,0.5956874697727498,0.9611347517730496,0.4979054096868257,"['IFIH1', 'JUN', 'CDKN1A', 'EGR3', 'IRF7', 'NFATC2', 'PIK3CD', 'FAS', 'NFATC1', 'TAB2', 'FOS']",0.8343293255055211,0,0,11
355,Endothelin Pathways WP2197,0.5984036596885463,1.0198010510510511,0.523657373038523,"['EDNRA', 'CALCRL']",0.8343293255055211,0,0,2
356,Fatty Acid Biosynthesis WP357,0.5984036596885463,1.0198010510510511,0.523657373038523,"['SCD', 'ACSL6']",0.8343293255055211,0,0,2
357,Sphingolipid Metabolism (general overview) WP4725,0.5984036596885463,1.0198010510510511,0.523657373038523,"['UGCG', 'UGT8']",0.8343293255055211,0,0,2
358,Toll-like Receptor Signaling related to MyD88 WP3858,0.5984036596885463,1.0198010510510511,0.523657373038523,"['IRF7', 'NFKB2']",0.8343293255055211,0,0,2
359,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5992406324789731,0.9833051563820795,0.5035427413748265,"['GABRA2', 'SHC1', 'GABRA5']",0.8343293255055211,0,0,3
360,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5992406324789731,0.9833051563820795,0.5035427413748265,"['JUN', 'MAP3K14', 'NFKB2']",0.8343293255055211,0,0,3
361,Vitamin D-sensitive calcium signaling in depression WP4698,0.5992406324789731,0.9833051563820795,0.5035427413748265,"['CALB1', 'ATP2B4', 'PVALB']",0.8343293255055211,0,0,3
362,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.602276459393264,0.9659809422032238,0.48978972523289055,"['PPP1R3G', 'PPP1R14A', 'XBP1', 'PPP1R3C']",0.8343293255055211,0,0,4
363,15q13.3 copy number variation syndrome WP4942,0.6058820101885332,1.1473628691983122,0.5749091295392704,['SERPINH1'],0.8343293255055211,0,0,1
364,"NAD metabolism, sirtuins and aging WP3630",0.6058820101885332,1.1473628691983122,0.5749091295392704,['NAMPT'],0.8343293255055211,0,0,1
365,NLR Proteins WP288,0.6058820101885332,1.1473628691983122,0.5749091295392704,['ERBIN'],0.8343293255055211,0,0,1
366,NO metabolism in cystic fibrosis WP4947,0.6058820101885332,1.1473628691983122,0.5749091295392704,['PRMT8'],0.8343293255055211,0,0,1
367,Estrogen signaling pathway WP712,0.6254867120985274,0.9660384068278806,0.45328955783924096,"['JUN', 'FOS']",0.8497177975678107,0,0,2
368,Photodynamic therapy-induced unfolded protein response WP3613,0.6254867120985274,0.9660384068278806,0.45328955783924096,"['XBP1', 'WARS']",0.8497177975678107,0,0,2
369,Pre-implantation embryo WP3527,0.6254867120985274,0.9660384068278806,0.45328955783924096,"['EGR1', 'ZFP36']",0.8497177975678107,0,0,2
370,Sphingolipid Metabolism (integrated pathway) WP4726,0.6254867120985274,0.9660384068278806,0.45328955783924096,"['UGT8', 'UGCG']",0.8497177975678107,0,0,2
371,Trans-sulfuration and one-carbon metabolism WP2525,0.6254867120985274,0.9660384068278806,0.45328955783924096,"['BHMT', 'GCLM']",0.8497177975678107,0,0,2
372,Mesodermal commitment pathway WP2857,0.6348928482658023,0.9275533874924823,0.4213866109048573,"['SMAD1', 'ARL4A', 'FZD4', 'SESN1', 'PBX3', 'ARID5B', 'HMGA2', 'RPL38', 'TBX6']",0.8572437178525434,0,0,9
373,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.644633668781972,1.0197843413033287,0.44775985056117895,['SMAD1'],0.8572437178525434,0,0,1
374,Ganglio Sphingolipid Metabolism WP1423,0.644633668781972,1.0197843413033287,0.44775985056117895,['ST8SIA1'],0.8572437178525434,0,0,1
375,Homologous recombination WP186,0.644633668781972,1.0197843413033287,0.44775985056117895,['POLD4'],0.8572437178525434,0,0,1
376,Matrix Metalloproteinases WP129,0.644633668781972,1.0197843413033287,0.44775985056117895,['MMP15'],0.8572437178525434,0,0,1
377,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.644633668781972,1.0197843413033287,0.44775985056117895,['HMGCS1'],0.8572437178525434,0,0,1
378,Monoamine GPCRs WP58,0.644633668781972,1.0197843413033287,0.44775985056117895,['CHRM5'],0.8572437178525434,0,0,1
379,Osteopontin Signaling WP1434,0.644633668781972,1.0197843413033287,0.44775985056117895,['MAP3K14'],0.8572437178525434,0,0,1
380,Physiological and pathological hypertrophy of the heart WP1528,0.6511297531186915,0.917652027027027,0.3937152464227746,"['JUN', 'FOS']",0.8636036725574223,0,0,2
381,Amino Acid metabolism WP3925,0.6552404421595657,0.9022506251736594,0.3814291796931728,"['ARG2', 'BHMT', 'WARS', 'OAT', 'P4HA2', 'GCLM']",0.8648371390531966,0,0,6
382,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6554916411077799,0.8993707559230296,0.37986698136410524,"['PSMD10', 'TUBB2B', 'RNF19A', 'HSPA1B', 'HSPA1A']",0.8648371390531966,0,0,5
383,Alanine and aspartate metabolism WP106,0.6795779508051518,0.9177215189873418,0.35450052811337096,['GPT'],0.8804814581125874,0,0,1
384,Biomarkers for pyrimidine metabolism disorders WP4584,0.6795779508051518,0.9177215189873418,0.35450052811337096,['NT5C'],0.8804814581125874,0,0,1
385,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.6795779508051518,0.9177215189873418,0.35450052811337096,['NFKB2'],0.8804814581125874,0,0,1
386,Mammalian disorder of sexual development WP4842,0.6795779508051518,0.9177215189873418,0.35450052811337096,['FGF9'],0.8804814581125874,0,0,1
387,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6795779508051518,0.9177215189873418,0.35450052811337096,['MAP3K14'],0.8804814581125874,0,0,1
388,RalA downstream regulated genes WP2290,0.6795779508051518,0.9177215189873418,0.35450052811337096,['YBX3'],0.8804814581125874,0,0,1
389,Type II diabetes mellitus WP1584,0.6795779508051518,0.9177215189873418,0.35450052811337096,['IRS1'],0.8804814581125874,0,0,1
390,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6821882533488453,0.8600750211327134,0.32893537181980465,"['IFNAR2', 'CXCL17', 'IRF7']",0.8815971274046616,0,0,3
391,Nanoparticle-mediated activation of receptor signaling WP2643,0.6981906765774444,0.8340755528255528,0.29965251695710954,"['FN1', 'PIK3CD']",0.8964584540703711,0,0,2
392,Sphingolipid pathway WP1422,0.6981906765774444,0.8340755528255528,0.29965251695710954,"['UGT8', 'UGCG']",0.8964584540703711,0,0,2
393,Common Pathways Underlying Drug Addiction WP2636,0.7008028390946948,0.833935295473757,0.29648792160056897,"['CAMK4', 'GRM1', 'GRIA4']",0.8964584540703711,0,0,3
394,PDGF Pathway WP2526,0.7008028390946948,0.833935295473757,0.29648792160056897,"['JUN', 'SHC1', 'FOS']",0.8964584540703711,0,0,3
395,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.711088648329198,0.8342155734560798,0.2844326201133133,['CD38'],0.905021916055343,0,0,1
396,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.711088648329198,0.8342155734560798,0.2844326201133133,['ALOX12'],0.905021916055343,0,0,1
397,Interleukin-11 Signaling Pathway WP2332,0.7185750152207903,0.8093332007359156,0.267472623341553,"['SOCS3', 'RPS6', 'ICAM1']",0.9105028407319445,0,0,3
398,BDNF-TrkB Signaling WP3676,0.7196781688092684,0.797737955346651,0.26241682153197626,"['SHC1', 'GAB1']",0.9105028407319445,0,0,2
399,AGE/RAGE pathway WP2324,0.72262130216821,0.8151908253431096,0.26483102778859097,"['LGALS3', 'JUN', 'IRS1', 'SHC1']",0.9105028407319445,0,0,4
400,Mitochondrial complex I assembly model OXPHOS system WP4324,0.72262130216821,0.8151908253431096,0.26483102778859097,"['NDUFA7', 'NDUFA2', 'NDUFA1', 'TMEM70']",0.9105028407319445,0,0,4
401,Canonical and non-canonical TGF-B signaling WP3874,0.7395028841212579,0.7646272855133615,0.23074700231234255,['LOXL2'],0.9139459008303807,0,0,1
402,Omega-3/Omega-6 FA synthesis WP4723,0.7395028841212579,0.7646272855133615,0.23074700231234255,['PLA2G5'],0.9139459008303807,0,0,1
403,Omega-9 FA synthesis WP4724,0.7395028841212579,0.7646272855133615,0.23074700231234255,['SCD'],0.9139459008303807,0,0,1
404,PPAR-alpha pathway WP2878,0.7395028841212579,0.7646272855133615,0.23074700231234255,['DBI'],0.9139459008303807,0,0,1
405,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7395028841212579,0.7646272855133615,0.23074700231234255,['BCL2L14'],0.9139459008303807,0,0,1
406,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7395028841212579,0.7646272855133615,0.23074700231234255,['F3'],0.9139459008303807,0,0,1
407,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7395028841212579,0.7646272855133615,0.23074700231234255,['FN1'],0.9139459008303807,0,0,1
408,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7398609673388796,0.764428490990991,0.2303169475344711,"['PIK3CD', 'PRKCQ']",0.9139459008303807,0,0,2
409,22q11.2 copy number variation syndrome WP4657,0.7471433871740384,0.8088484546360917,0.23577783751351802,"['ACTA2', 'SREBF1', 'AIFM3', 'OAT', 'THAP7', 'HES1']",0.9206852497205753,0,0,6
410,Phosphodiesterases in neuronal function WP4222,0.751639747231456,0.7642293603832065,0.21818605278422198,"['PDE5A', 'ADCY2', 'PDE8B']",0.9239669087918385,0,0,3
411,Lipid Metabolism Pathway WP3965,0.7587877884172037,0.7337837837837838,0.202548637760803,"['PRKAR2B', 'HILPDA']",0.9286505021370767,0,0,2
412,Chemokine signaling pathway WP3929,0.759134934286658,0.8145632899452934,0.2244738800623481,"['GNG3', 'GRK5', 'SHC1', 'PARD3', 'PIK3CD', 'PRKX', 'ADCY2', 'CXCL14']",0.9286505021370767,0,0,8
413,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7651247061496212,0.705744888023369,0.18893951169848225,['SFRP4'],0.9336955741230188,0,0,1
414,Modulators of TCR signaling and T cell activation WP5072,0.7669642216010512,0.743505974275205,0.19726338117103528,"['ELOB', 'PRKCQ', 'MAP3K14']",0.9336955741230188,0,0,3
415,3q29 copy number variation syndrome WP4906,0.778102657476966,0.7483683828861494,0.18776324223399413,"['JUN', 'TFRC', 'PIGM', 'SLC51A']",0.9352448994865704,0,0,4
416,AMP-activated protein kinase (AMPK) signaling WP1403,0.778102657476966,0.7483683828861494,0.18776324223399413,"['SREBF1', 'CDKN1A', 'CRTC2', 'PIK3CD']",0.9352448994865704,0,0,4
417,Pathways affected in adenoid cystic carcinoma WP3651,0.778102657476966,0.7483683828861494,0.18776324223399413,"['NOTCH1', 'MYCBP', 'ERBIN', 'ARID5B']",0.9352448994865704,0,0,4
418,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7815090926645473,0.7238732926992036,0.17845539291372156,"['ADCY2', 'SYNE3', 'SYNE2']",0.9352448994865704,0,0,3
419,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7882283299876587,0.6552742616033755,0.15593395965025944,['PLA2G5'],0.9352448994865704,0,0,1
420,Overview of interferons-mediated signaling pathway WP4558,0.7882283299876587,0.6552742616033755,0.15593395965025944,['IFNAR2'],0.9352448994865704,0,0,1
421,Triacylglyceride synthesis WP325,0.7882283299876587,0.6552742616033755,0.15593395965025944,['MOGAT1'],0.9352448994865704,0,0,1
422,Leptin signaling pathway WP2034,0.7897068377270717,0.7512388778612179,0.177362611410697,"['SOCS3', 'IRS1', 'SHC1', 'RPS6', 'PLCG2']",0.9352448994865704,0,0,5
423,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7897068377270717,0.7512388778612179,0.177362611410697,"['EGF', 'PIK3CD', 'NRG1', 'MAP3K14', 'IGF1R']",0.9352448994865704,0,0,5
424,Development of ureteric collection system WP5053,0.793082433251821,0.6793043043043043,0.1574818340771827,"['SMAD1', 'SPRY1']",0.9352448994865704,0,0,2
425,Nucleotide Excision Repair WP4753,0.7952961975381477,0.7052474153065869,0.16153033219365723,"['POLE4', 'POLD4', 'RPA3']",0.9352448994865704,0,0,3
426,Pathways Regulating Hippo Signaling WP4540,0.8005508865986655,0.739053836278714,0.1644063542143633,"['PRKAR2B', 'PRKCQ', 'FGFR3', 'IGF1R', 'TEAD3']",0.9352448994865704,0,0,5
427,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8083489587063785,0.687552831783601,0.14628472651466687,"['IFIH1', 'RNF125', 'IRF7']",0.9352448994865704,0,0,3
428,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8083489587063785,0.687552831783601,0.14628472651466687,"['CAMK4', 'PIK3CD', 'GRM1']",0.9352448994865704,0,0,3
429,Synaptic Vesicle Pathway WP2267,0.8083489587063785,0.687552831783601,0.14628472651466687,"['SNAP25', 'RIMS1', 'SLC22A3']",0.9352448994865704,0,0,3
430,Prader-Willi and Angelman Syndrome WP3998,0.8085587482363715,0.6549831081081081,0.13918518071863714,"['PCSK1', 'GABRA5']",0.9352448994865704,0,0,2
431,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8085587482363715,0.6549831081081081,0.13918518071863714,"['RPS6', 'NFKB2']",0.9352448994865704,0,0,2
432,Nucleotide metabolism WP404,0.809061063841557,0.6115330520393811,0.12957216373927571,['SAT1'],0.9352448994865704,0,0,1
433,Proteoglycan biosynthesis WP4784,0.809061063841557,0.6115330520393811,0.12957216373927571,['XYLT1'],0.9352448994865704,0,0,1
434,"Relationship between inflammation, COX-2 and EGFR WP4483",0.809061063841557,0.6115330520393811,0.12957216373927571,['PIK3CD'],0.9352448994865704,0,0,1
435,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.809061063841557,0.6115330520393811,0.12957216373927571,['EGR1'],0.9352448994865704,0,0,1
436,Transcription co-factors SKI and SKIL protein partners WP4533,0.809061063841557,0.6115330520393811,0.12957216373927571,['TEAD3'],0.9352448994865704,0,0,1
437,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8229944538502962,0.6323392357875116,0.12318336161966689,"['NFATC2', 'NFATC1']",0.9449755524043433,0,0,2
438,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8278459466173235,0.573259493670886,0.10830488239026506,['MRAS'],0.9449755524043433,0,0,1
439,Kallmann's Syndrome WP5074,0.8278459466173235,0.573259493670886,0.10830488239026506,['PRKCQ'],0.9449755524043433,0,0,1
440,Methionine De Novo and Salvage Pathway WP3580,0.8278459466173235,0.573259493670886,0.10830488239026506,['BHMT'],0.9449755524043433,0,0,1
441,Amyotrophic lateral sclerosis (ALS) WP2447,0.8364444363668831,0.611204954954955,0.10915826182594618,"['SLC1A2', 'TNFRSF1A']",0.9449755524043433,0,0,2
442,p38 MAPK Signaling Pathway WP400,0.8364444363668831,0.611204954954955,0.10915826182594618,"['SHC1', 'HSPB1']",0.9449755524043433,0,0,2
443,Parkinson's disease pathway WP2371,0.8364444363668831,0.611204954954955,0.10915826182594618,"['CCNE2', 'CASP6']",0.9449755524043433,0,0,2
444,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8447841278003246,0.5394887068751552,0.0909978013983201,['SREBF1'],0.9449755524043433,0,0,1
445,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.8447841278003246,0.5394887068751552,0.0909978013983201,['RPS6'],0.9449755524043433,0,0,1
446,Gastric Cancer Network 2 WP2363,0.8447841278003246,0.5394887068751552,0.0909978013983201,['S100A6'],0.9449755524043433,0,0,1
447,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.8447841278003246,0.5394887068751552,0.0909978013983201,['ETV6'],0.9449755524043433,0,0,1
448,Immune response to tuberculosis WP4197,0.8447841278003246,0.5394887068751552,0.0909978013983201,['IFNAR2'],0.9449755524043433,0,0,1
449,Integrated Cancer Pathway WP1971,0.8489628507985879,0.5914341761115954,0.09684134331043151,"['BARD1', 'CDKN1A']",0.9449755524043433,0,0,2
450,Cannabinoid receptor signaling WP3869,0.8600570141537254,0.5094702297233943,0.07680599780249084,['PRKAR2B'],0.9449755524043433,0,0,1
451,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8600570141537254,0.5094702297233943,0.07680599780249084,['IRAK2'],0.9449755524043433,0,0,1
452,Glycerolipids and Glycerophospholipids WP4722,0.8600570141537254,0.5094702297233943,0.07680599780249084,['PNPLA3'],0.9449755524043433,0,0,1
453,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8600570141537254,0.5094702297233943,0.07680599780249084,['LAMA5'],0.9449755524043433,0,0,1
454,IL-7 signaling pathway WP205,0.8600570141537254,0.5094702297233943,0.07680599780249084,['IL7'],0.9449755524043433,0,0,1
455,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.8600570141537254,0.5094702297233943,0.07680599780249084,['NAMPT'],0.9449755524043433,0,0,1
456,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8600570141537254,0.5094702297233943,0.07680599780249084,['NFATC2'],0.9449755524043433,0,0,1
457,Copper homeostasis WP3286,0.860602735225384,0.5728990709459459,0.08600491491528414,"['JUN', 'SOD3']",0.9449755524043433,0,0,2
458,G13 Signaling Pathway WP524,0.860602735225384,0.5728990709459459,0.08600491491528414,"['PIK3CD', 'PIP4K2A']",0.9449755524043433,0,0,2
459,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.860602735225384,0.5728990709459459,0.08600491491528414,"['ACTA2', 'TEAD3']",0.9449755524043433,0,0,2
460,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8726731584761813,0.5975412547318902,0.08138164249491166,"['IFNAR2', 'SOCS3', 'OSMR']",0.9553349582685684,0,0,3
461,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8738282058766073,0.48261159227181877,0.06509054136978877,['HGF'],0.9553349582685684,0,0,1
462,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8786412962538162,0.6209527087097422,0.08033795871643358,"['SLCO1C1', 'NOTCH1', 'RPS6', 'PRKCQ']",0.9585177777314358,0,0,4
463,Oxidative phosphorylation WP623,0.8813084341820889,0.5847736551500873,0.07388475884309555,"['NDUFA7', 'NDUFA4', 'NDUFA2']",0.9593508657187317,0,0,3
464,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.887702660319645,0.6977161124951399,0.0831108507279972,"['EGR1', 'JUN', 'IRS1', 'SHC1', 'CAMK4', 'RPS6', 'IRS2', 'FOS', 'SH2B2']",0.9642287517265109,0,0,9
465,Acute viral myocarditis WP4298,0.8970284244916515,0.5608018355271103,0.06094106190197961,"['LAMA2', 'CASP6', 'NFKB2']",0.9722630665457902,0,0,3
466,Regulation of Microtubule Cytoskeleton WP2038,0.9073696614998834,0.4952520087655223,0.048141143290008674,"['PARD6A', 'CAMK4']",0.9794392952228667,0,0,2
467,MTHFR deficiency WP4288,0.9075360136291245,0.41668584579976986,0.04042770629454977,['BHMT'],0.9794392952228667,0,0,1
468,Glycerophospholipid Biosynthetic Pathway WP2533,0.9166379482563912,0.3985323793799303,0.03468933699098391,['PIK3CD'],0.9840735799115751,0,0,1
469,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9166379482563912,0.3985323793799303,0.03468933699098391,['VEGFA'],0.9840735799115751,0,0,1
470,Energy Metabolism WP1541,0.9215927176949671,0.4697678447678448,0.03835743279916805,"['CAMK4', 'TFB2M']",0.9840735799115751,0,0,2
471,Eukaryotic Transcription Initiation WP405,0.9215927176949671,0.4697678447678448,0.03835743279916805,"['POLR2I', 'POLR2K']",0.9840735799115751,0,0,2
472,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9215927176949671,0.4697678447678448,0.03835743279916805,"['CP', 'FTL']",0.9840735799115751,0,0,2
473,Nuclear receptors WP170,0.9322438778514286,0.36658227848101266,0.0257197158262287,['RXRG'],0.9912466549306328,0,0,1
474,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.9322438778514286,0.36658227848101266,0.0257197158262287,['CAMK4'],0.9912466549306328,0,0,1
475,Intraflagellar transport proteins binding to dynein WP4532,0.9389152305902053,0.35245050308341447,0.02221498344443349,['IFT27'],0.9962384762472917,0,0,1
476,Ciliopathies WP4803,0.9418848476516518,0.6387659959088531,0.03824436013630428,"['EVC2', 'DNAH11', 'TMEM17', 'GPR161', 'SPAG1', 'IFT27', 'PKD1L1', 'CCDC65', 'CFAP53', 'CCDC28B']",0.9972898386899843,0,0,10
477,Glycolysis and Gluconeogenesis WP534,0.944930190323403,0.3393655258634162,0.019223097845910204,['PFKP'],0.9984168048700107,0,0,1
478,Fatty acid beta-oxidation WP143,0.9503532900771273,0.32721518987341774,0.0166622814941147,['ACSL6'],0.9998265954878688,0,0,1
479,miRNA regulation of prostate cancer signaling pathways WP3981,0.9503532900771273,0.32721518987341774,0.0166622814941147,['CDKN1A'],0.9998265954878688,0,0,1
480,Androgen receptor signaling pathway WP138,0.9522158052265417,0.5012168833878033,0.024541374830565538,"['CDKN1A', 'JUN', 'LIMK2', 'FLNA']",0.9998265954878688,0,0,4
481,DNA IR-damage and cellular response via ATR WP4016,0.9544263316961321,0.45752324598478444,0.021341088900458802,"['BARD1', 'BCL6', 'PML']",0.9999956371298317,0,0,3
482,Rett syndrome causing genes WP4312,0.9567746502816478,0.3980243830787309,0.017587658806844913,"['HAP1', 'SYNE2']",0.9999956371298317,0,0,2
483,Disruption of postsynaptic signaling by CNV WP4875,0.9636253367798086,0.2954675377705186,0.01094787438312738,['GRM1'],0.9999956371298317,0,0,1
484,MAPK Cascade WP422,0.9636253367798086,0.2954675377705186,0.01094787438312738,['JUN'],0.9999956371298317,0,0,1
485,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9636253367798086,0.2954675377705186,0.01094787438312738,['ACTN2'],0.9999956371298317,0,0,1
486,7q11.23 copy number variation syndrome WP4932,0.9664150858769996,0.46887066684021,0.01601748542215807,"['CLIP2', 'SNAP25', 'FAS', 'NRG1']",0.9999956371298317,0,0,4
487,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9694625516920565,0.3660472972972973,0.011352382765484356,"['FN1', 'ANGPTL1']",0.9999956371298317,0,0,2
488,Pathways in clear cell renal cell carcinoma WP4018,0.9735348316316008,0.4094573623850317,0.010982332305884397,"['ENPP3', 'PFKP', 'VEGFA']",0.9999956371298317,0,0,3
489,Thermogenesis WP4321,0.9766009131156819,0.4404215848164231,0.010427946583397026,"['RPS6KA2', 'RPS6', 'ACSL6', 'ADCY2']",0.9999956371298317,0,0,4
490,Integrin-mediated Cell Adhesion WP185,0.9822226710992091,0.38084671738517895,0.00683134037649005,"['CAV3', 'SHC1', 'ITGA3']",0.9999956371298317,0,0,3
491,ATM Signaling Network in Development and Disease  WP3878,0.9824021062218968,0.24088385520763936,0.004276791108553477,['HSPB1'],0.9999956371298317,0,0,1
492,Splicing factor NOVA regulated synaptic proteins WP4148,0.9824021062218968,0.24088385520763936,0.004276791108553477,['EPB41'],0.9999956371298317,0,0,1
493,Pathogenic Escherichia coli infection WP2272,0.9841365063825848,0.23468570810342962,0.0037527806683235574,['TUBB2B'],0.9999956371298317,0,0,1
494,Wnt Signaling Pathway WP363,0.9871096205706594,0.2231964598126994,0.0028957913368885314,['NFATC2'],0.9999956371298317,0,0,1
495,16p11.2 proximal deletion syndrome WP4949,0.9874206859882048,0.30475788288288286,0.003857961557215745,"['MVP', 'TBX6']",0.9999956371298317,0,0,2
496,Fragile X Syndrome  WP4549,0.988555077023859,0.4264562741855073,0.004908904117625871,"['SHC1', 'CAMK4', 'GAB1', 'SLC6A1', 'GRM1']",0.9999956371298317,0,0,5
497,Alzheimer's disease WP2059,0.9894932734213747,0.29487249346120314,0.003114535252505964,"['FAS', 'TNFRSF1A']",0.9999956371298317,0,0,2
498,Translation Factors WP107,0.9923284543737055,0.1988442487616951,0.001531324077315487,['EEF1B2'],0.9999956371298317,0,0,1
499,DNA Repair Pathways Full Network WP4946,0.9924339244787616,0.37249214406574815,0.00282901952778892,"['POLE4', 'POLD4', 'RPA3', 'APEX1']",0.9999956371298317,0,0,4
500,Joubert Syndrome WP4656,0.9933232956685668,0.27274102460669625,0.001827117552439741,"['TMEM17', 'FLNA']",0.9999956371298317,0,0,2
501,Endoderm differentiation WP2853,0.997135315728571,0.29111886476861926,0.0008351604404669604,"['NOTCH1', 'SESN1', 'PBX3']",0.9999956371298317,0,0,3
502,Genes related to primary cilium development (based on CRISPR) WP4536,0.9973696331229776,0.28802776171197225,0.0007586168423486091,"['EVC2', 'TMEM17', 'IFT27']",0.9999956371298317,0,0,3
503,mRNA Processing WP411,0.9999940108912986,0.07383623203320641,4.4221454398700843e-07,['U2AF1'],0.9999956371298317,0,0,1
504,Ciliary landscape WP4352,0.9999956371298317,0.13902074257103844,6.065307736397241e-07,"['CDH23', 'IFT27', 'MAPRE2']",0.9999956371298317,0,0,3
